111 results on '"L. Tazza"'
Search Results
2. Team dell'accesso vascolare: modelli organizzativi
- Author
-
L. Carbonari, F. Galli, and L. Tazza
- Subjects
Emodialisi ,Accesso vascolare ,Aspetti economici ,Modello organizzativo sanitario ,Internal medicine ,RC31-1245 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Il nefrologo, che si confronta con tutti i problemi inerenti all'insufficienza renale, è anche da sempre principale gestore della terapia emodialitica. Per tale motivo tocca al nefrologo, in prima istanza, occuparsi dell'accesso vascolare disponendone l'allestimento, la sorveglianza e la manutenzione a garanzia della possibilità di effettuare il trattamento sostitutivo. Rispetto a quanto avviene in altri paesi, in Italia l'attività dell'accesso non è ad oggi standardizzata né strutturata; ciascun centro dialisi si organizza in funzione delle capacità dei nefrologi ivi operanti e delle collaborazioni di altri specialisti presenti nell'ospedale, spesso senza un percorso strutturato e con modalità di intervento per lo più fondate sulla disponibilità personale e sul volontarismo. Partendo dalla storia dell'accesso vascolare in Italia, abbiamo individuato tre tipologie organizzative che correlano, da un lato, con il contesto storico in cui sono sorte e, dall'altro, con il progresso, in termini di dispositivi medici e competenze specialistiche, che ha via via modificato i comportamenti. Il modello organizzativo “primordiale” vede il nefrologo confezionare e correggere personalmente gli accessi disponibili in quell'epoca. Nel modello polispecialistico, che nasce successivamente, il nefrologo inizia a delegare ad alti specialisti, più competenti sul versante tecnico, singole fasi del lavoro; resta colui che inizia il percorso e detta i tempi ma perde, talora, il controllo della gestione complessiva. Nel modello strutturale integrato, ideale ma non ancora integralmente realizzabile, il chirurgo dedicato all'accesso dialitico ed il radiologo interventista interagiscono da vicino con il nefrologo, che funge da regista, coordinatore e amministratore di tutto il processo di gestione dell'accesso vascolare. La formazione culturale specifica e necessaria e la conoscenza del programma terapeutico complessivo sono condivise dal team dell'accesso. In tale modello integrato dovrebbero essere trovate soluzioni perché anche la responsabilità professionale ed il rimborso amministrativo risultino bene “integrate” tra i vari specialisti ed operatori sanitari che partecipano all'attività. Il rimborso a D.R.G. com'è attualmente regolato presenta incongruenze e può produrre effetti contrari alla migliore cura del paziente. Le Aziende ospedaliere attualmente non riservano all'accesso vascolare, parte irrinunciabile della terapia dialitica, l'attenzione necessaria e non comprendono come una corretta gestione del problema, fondata su percorsi organizzati, migliori la qualità di vita del paziente e contenga il costo assistenziale della dialisi. La gestione complessiva dell'accesso vascolare dialitico non può più fondarsi, attualmente, solo sulla “buona volontà” del nefrologo dializzatore, ma richiede regole strutturali. Pertanto andrebbero definite le motivazioni professionali mediante l'attribuzione di precisi compiti, con lo scopo di meglio identificare e minimizzare il “rischio organizzativo”. L'individuazione di meccanismi economico-organizzativi-normativi che privilegino anzitutto l'ottenimento del risultato e, a seguire, che premino il lavoro di tutta la squadra che l'ha generato è la condizione prima per creare il modello integrato. è più che mai tempo che l'accesso vascolare entri a pieno titolo nel sistema qualità della dialisi e per farlo, a nostro avviso, il modello organizzativo integrato è l'unica soluzione possibile.
- Published
- 2018
- Full Text
- View/download PDF
3. Terapie combinate plurime per prolungare la sopravvivenza delle fistole arterovenose native
- Author
-
L. Carbonari, E. Far Reza, P. Pezzotti, R. Stanziale, M. Lodi, and L. Tazza
- Subjects
Emodialisi ,Accesso vascolare ,Fistole arterovenose native ,Protesi vascolari ,Angioplastica percutanea ,Internal medicine ,RC31-1245 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
La Fistola Arterovenosa Nativa rappresenta a tutt'oggi il gold standard degli accessi vascolari in emodialisi. Tuttavia essa non è applicabile a tutti i pazienti. Le protesi rappresentano una seconda scelta percorribile in alternativa al Catetere Venoso centrale a permanenza, ma sono gravate da maggiori complicanze, hanno una durata inferiore e richiedono un'adeguata sorveglianza e manutenzione. I due casi clinici qui presentati, illustrano come strategie combinate plurime, chirurgiche ed endovascolari, perfettamente complementari e sinergiche, possano garantirne la pervietà a lungo termine e ridurre il ricorso all'uso dei CVC.
- Published
- 2018
- Full Text
- View/download PDF
4. DIALYSIS VASCULAR ACCESS
- Author
-
N. Fontsere, G. Mestres, M. Burrel, M. Barrufet, X. Montana, M. Arias, R. Ojeda, F. Maduell, J. M. Campistol, P. Nagaraja, D. Rees, T. Husein, J. Chess, C.-C. Lin, W.-C. Yang, M. Khosravi, H. Kandil, J. Cross, S. Hopkins, S. Collier, D. Lopes, S. Pereira, A. M. Gomes, A. Ventura, V. Martins, J. Seabra, T. C. Rothuizen, F. Damanik, M. J. T. Visser, T. Lavrijsen, M. A. J. Cox, L. Moroni, T. J. Rabelink, J. I. Rotmans, C. Cardozo, J. Donate, A. Soriano, M. Muros, M. Pons, J. Mensa, J. F. Navarro-Gonzalez, A. Wijewardane, A. Murley, S. Powers, C. Allen, J. Baharani, T. Wilmink, M. Esenturk, M. Zengin, M. Dal, N. Tahtal, K. Shibata, T. Shinzato, H. Satta, M. Nishihara, N. Koguchi, T. Kuji, S. Kawata, T. Kaneda, G. Yasuda, J. Scrivano, L. Pettorini, T. Rutigliano, G. M. Ciavarella, L. De Biase, G. Punzo, P. Mene, N. Pirozzi, W. El Haggan, K. Belazrague, S. Ehoussou, V. Foucher, M. El Salhy, G. Ouellet, J. Davis, P. Caron, M. Leblanc, F. Romitelli, L. Fazzari, G. Ortu, E. Di Stasio, G. Loizzo, S. M. Vigano, G. Bacchini, E. Rocchi, V. Sala, G. Pontoriero, K. Letachowicz, T. Go biowski, M. Kusztal, W. Letachowicz, W. Weyde, M. Klinger, L. Hollingsworth, R. Roca-Tey, R. Samon, O. Ibrik, A. Roda, J. C. Gonzalez-Oliva, R. Martinez-Cercos, J. Viladoms, C. J. Renaud, E. K. Lim, T. Y. Seow, H. S. Teh, J. Tosic, A. Jankovic, P. Djuric, V. Radovic Maslarevic, J. Popovic, N. Dimkovic, A. Kazantzi, K. Trigka, F. Buono, S. Laurino, G. Toriello, R. Di Luccio, A. Galise, Y. O. Kim, S. A. Yoon, Y. S. Kim, S. J. Choi, J. W. Min, M. A. Cheong, M. Asano, K. Oguchi, A. Saito, Y. Onishi, Y. Yamamoto, S. Fukuhara, T. Akiba, T. Akizawa, K. Kurokawa, M. Guedes Marques, J. Ibeas, P. Maia, P. Ponce, K. Y. Chang, H. S. Park, H. W. Kim, B. S. Choi, C. W. Park, C. W. Yang, D. C. Jin, E. Likaj, S. Seferi, G. Caco, E. Petrela, M. Barbullushi, A. Idrizi, N. Thereska, C. Lomonte, F. Casucci, P. Libutti, P. Lisi, C. Basile, P. Ancarani, G. Valsuani, L. Cavallo, D. Parodi, C. Lorusso, C. Renaud, B. C. Lai, S. Tho, L. Yeoh, C. Botelho, A. Yankovoy, S. Alexandr, A. Smoliacov, V. Stepanov, C. Parker, P. Davies, S. Taylor, A. Mikhail, J. Gubensek, V. Persic, B. Vajdic, R. Ponikvar, J. Buturovic-Ponikvar, U. Hadimeri, A. V. Warme, B. Stegmayr, S. Suvakov, T. Damjanovic, S. Bajcetic, V. Radovic-Maslarevic, T. Simic, M. Rroji, H. L. Chua, H. Kanda, S. L. See, N. C. Liew, K. Tsuchida, T. Tomo, M. Fukasawa, S. Kawashima, J. Minakuchi, V. Thanaraj, A. Dhaygude, K. Ikeda, G. Forneris, P. Cecere, M. Pozzato, M. Trogolo, A. Vallero, P. Mesiano, D. Roccatello, L. Keskin, J. R. Casey, C. S. Hanson, W. C. Winkelmayer, J. Craig, S. Palmer, G. Strippoli, A. Tong, D. Ferrara, S. Scamarda, L. Bernardino, L. Amico, M. C. Lorito, f. Incalcaterra, L. Visconti, G. Visconti, F. Valenza, F. D'Amato, A. Di Napoli, L. Tazza, S. Chicca, E. Lapucci, P. Silvestri, D. Di Lallo, P. Michelozzi, and M. Davoli
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Vascular access ,medicine ,Intensive care medicine ,Dialysis (biochemistry) ,business - Published
- 2014
- Full Text
- View/download PDF
5. DIALYSIS. PATHOPHYSIOLOGY AND CLINICAL STUDIES
- Author
-
J. K. Humalda, S. Assa, G. J. Navis, C. F. M. Franssen, M. H. De Borst, H. Ogawa, Y. Ota, T. Watanabe, Y. Watanabe, H. Nishii, A. Sato, J. Waniewski, M. Debowska, A. Wojcik-Zaluska, A. Ksiazek, W. Zaluska, C. M. Guastoni, C. Turri, L. Toma, G. Rombola, G. Frattini, G. Romei Longhena, U. Teatini, D.-C. Siriopol, S. Stuard, A. Ciolan, G. Mircescu, D. Raluca, I. Nistor, A. Covic, C. L. De Roij Van Zuijdewijn, I. Chapdelaine, M. J. Nube, P. J. Blankestijn, M. L. Bots, S. J. Konings, M. A. Van Den Dorpel, N. C. Van Der Weerd, P. M. Ter Wee, M. P. Grooteman, P. S. Djuric, A. Jankovic, J. Tosic, S. Bajcetic, T. Damjanovic, J. Popovic, N. Dimkovic, J. Marinkovic, Z. Djuric, V. Knezevic, T. Lazarevic, S. Ljubenovic, R. Markovic, V. Rabrenovic, L. Djukanovic, V. Radovic Maslarevic, V. Mathrani, P. Drew, J. I. Chess, A. I. Williams, S. Robertson, M. Jibani, V. I. Aithal, M. Kumwenda, G. Roberts, A. I. Mikhail, A. E. Grzegorzewska, G. Ostromecki, A. Mostowska, A. Sowi ska, P. P. Jagodzi ski, H.-Y. Wu, H.-Y. Chen, S.-P. Hsu, M.-F. Pai, J.-Y. Yang, Y.-S. Peng, M. Hirose, T. Hasegawa, N. Kaneshima, F. Sasai, D. Komukai, K. Takahashi, F. Koiwa, K. Shishido, A. Yoshimura, G. Selim, O. Stojceva-Taneva, L. Tozija, P. Dzekova-Vidimliski, L. Trajceska, Z. Petronievic, S. Gelev, V. Amitov, A. Sikole, S. J. Moon, S. Y. Yoon, D. H. Shin, J. E. Lee, H.-J. Kim, H.-C. Park, D. Hadjiyannakos, V. Filiopoulos, G. Loukas, S. Pagonis, C. Andriopoulos, A. Drakou, D. Vlassopoulos, C. Catarino, P. Cunha, S. Ribeiro, P. Rocha-Pereira, F. Reis, M. Sameiro-Faria, V. Miranda, E. Bronze-Rocha, L. Belo, E. Costa, A. Santos-Silva, A. De Mauri, M. Brambilla, D. Chiarinotti, D. Lizio, R. Matheoud, N. Conti, M. M. Conte, A. Carriero, M. De Leo, A. V. Karpetas, P. A. Sarafidis, P. I. Georgianos, G. Koutroumpas, D. Divanis, P. Vakianis, G. Tzanis, K. Raptopoulou, A. Protogerou, D. Stamatiadis, C. Syrganis, V. Liakopoulos, G. Efstratiadis, A. N. Lasaridis, M. Tersi, D. N. Stamatiadis, P. Kuczera, M. Adamczak, A. Wiecek, S. Bove, B. Giacon, R. Corradini, E. Prati, M. Brognoli, A. Tommasi, L. Sereni, G. Palladino, H. Moriya, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, S. Hidaka, T. Ohtake, S. Kobayashi, A. Moura, J. Madureira, P. Alija, J. C. Fernandes, J. G. Oliveira, M. Lopez, M. Filgueiras, L. Amado, M. Vieira, J.-H. Seok, H. Y. Choi, S. K. Ha, H. C. Park, M. Bossola, A. Laudisio, M. Antocicco, L. Tazza, G. Colloca, M. Tosato, G. Zuccala, E. M. Ettema, J. Kuipers, H. Groen, R. T. Gansevoort, K. Stade, S. J. L. Bakker, C. A. J. M. Gaillard, R. Westerhuis, J. Bacchetta, K. Couchoud, S. Semlali, A.-L. Sellier-Leclerc, A. Bertholet-Thomas, R. Cartier, P. Cochat, B. Ranchin, J. C. Kim, K. Park, C. Van Ende, D. Wilmes, F. E. Lecouvet, L. Labriola, R. Cuvelier, G. Van Ingelgem, M. Jadoul, C. Doriana, P. David, F. Capurro, M. Brustia, C. E. Ruva, S. Giungi, E. Di Stasio, S. Lemesch, B. Leber, A. Horvath, W. Ribitsch, G. Schilcher, G. Zettel, M. Tawdrous, A. R. Rosenkranz, V. Stadlbauer-Kollner, H. Matsushima, A. Oyama, E. Bosch Benitez-Parodi, E. Baamonde Laborda, F. Batista Garcia, G. Perez Suarez, G. Anton Perez, C. Garcia Canton, A. Toledo Gonzalez, M. M. Lago Alonso, M. D. Checa Andres, G. Cobo, C. Di Gioia, R. Camacho, C. Garcia Lacalle, O. Ortega, I. Rodriguez, J. Herrero, A. Oliet, M. Ortiz, C. Mon, A. Vigil, P. Gallar, V. Pellu, P. E. Nebiolo, K. Sasaki, S. Yamguchi, A. Hesaka, E. Iwahashi, S. Sakai, T. Fujimoto, S. Minami, Y. Fujita, K. Yokoyama, E. Shutov, G. Ryabinskya, S. Lashutin, E. Gorelova, E. Volodicheva, M. A. Podesta, G. Cancarini, D. Cucchiari, A. Montanelli, S. Badalamenti, G. Graziani, E. Distasio, I. Pchelin, A. Shishkin, Y. Fedorova, C.-C. Kao, T.-S. Chu, T.-J. Tsai, K.-D. Wu, M.-S. Wu, V. Raikou, P. Kaisidis, E. Tsamparlis, P. Kanellopoulos, J. Boletis, A. Ueda, A. Hirayama, S. Owada, K. Nagai, C. Saito, and K. Yamagata
- Subjects
03 medical and health sciences ,Transplantation ,medicine.medical_specialty ,0302 clinical medicine ,Nephrology ,business.industry ,030232 urology & nephrology ,medicine ,030204 cardiovascular system & hematology ,Intensive care medicine ,Dialysis (biochemistry) ,business ,Pathophysiology - Published
- 2014
- Full Text
- View/download PDF
6. Vascular access
- Author
-
L. Coentrao, C. Ribeiro, C. Santos-Araujo, R. Neto, M. Pestana, E. Rahman, H. Rahman, D. Ahmed, D. Mousa, M. El Bishlawi, H. Shibahara, N. Shibahara, S. Takahashi, E. Dupuis, X. Duval, Q. Dornic, C. Bonnal, J.-C. Lucet, O. Cerceau, C. Randoux, C. Balde, F. Besson, F. Mentre, F. Vrtovsnik, G. Koutroubas, P. Malindretos, G. Zagotsis, P. Makri, C. Syrganis, E. Mambelli, E. Mancini, C. Elia, V. Guadagno, M. G. Facchini, A. Zucchelli, M. Grazia, L. Patregnani, A. Santoro, G. Stefan, S. Stancu, C. Capusa, O. R. Ailioaiei, G. Mircescu, S. Anwar, C. Little, R. Kingston, P. Diwakar, R. Kaikini, E. Nikolaou, G. Loukas, A. Sabry, K. Alsaran, S. Al Sherbeiny, M. Abdulkader, I. Kwak, S. Song, E. Seong, S. Lee, D. Lee, I. Kim, H. Rhee, F. Silva, J. Queiros, J. Malheiro, A. Cabrita, A. Rocha, P. Bamidis, C. Liaskos, I. Chryssogonidis, C. Frantzidis, A. Papagiannis, D. Vrochides, A. Lasaridis, P. Nikolaidis, S. Kotwal, C. Muir, C. Hawley, P. Snelling, M. Gallagher, M. Jardine, K. Shibata, Y. Toya, S. Umemura, T. Iwamoto, S. Ono, E. Ikeda, A. Kitazawa, T. Kuji, N. Koguchi, H. Satta, M. Nishihara, S. Kawata, T. Kaneda, Y. Yamada, T. Murakami, M. Yanagi, G. Yasuda, S. Mathieu, D. Yves, T. Jean-Michel, Q. Nicolas, C. Jean-Francois, M. Ibrahim, M. Abdel Salam, A. Awadalla, W. Bichari, S. Zaki, R. Roca-Tey, R. Samon, O. Ibrik, A. Roda, J. C. Gonzalez-Oliva, R. Martinez-Cercos, J. Viladoms, C.-C. Lin, W.-C. Yang, Y.-O. Kim, S.-A. Yoon, Y.-S. Yun, H.-C. Song, B.-S. Kim, M.-A. Cheong, T. Ogawa, T. Kiba, S. Okazaki, M. Hatano, M. Iwanaga, C. Noiri, A. Matsuda, H. Hasegawa, T. Mitarai, A. DI Napoli, D. DI Lallo, L. Tazza, C. De Cicco, M. F. Salvatori, S. Chicca, G. Guasticchi, S. Gelev, L. Trajceska, E. Srbinovska, S. Pavleska, A. Oncevski, P. Dejanov, V. Gerasomovska, G. Selim, A. Sikole, S. Wilson, T. Mayne, M. Krishnan, J. Holland, A. Volz, L. Good, A. Nissenson, A. Stavroulopoulos, V. Aresti, G. Maragkakis, S. Kyriakides, C. Rikker, E. Juhasz, L. Tornoci, S. Tovarosi, J. Greguschik, O. Mag, L. Rosivall, T. Golebiowski, E. Watorek, M. Kusztal, K. Letachowicz, W. Letachowicz, K. Madziarska, H. Augustyniak Bartosik, M. Krajewska, W. Weyde, M. Klinger, A. Capitanini, S. Lange, A. Cupisti, T. Schier, G. Gobel, C. Bosmuller, I. Gruber, M. Tiefenthaler, T. Shipley, J. Adam, D. Sweeney, S. Fenwick, H. Mansy, S. Ahmed, I. Moore, P. Vigeral, S. Saksi, M. Flamant, H. Boulanger, W.-D. Park, M. A. Cheong, M. Nikam, A. Tavakoli, E. Chemla, J. Evans, H. Malete, L. Matyas, I. Mogan, M. Lazarides, A. Ebner, Y. Shi, J. Zhang, J. Cheng, L. R. Frank, H. Melanie, B. Dominique, G. Michel, K. Ikeda, T. Yasuda, H. Yotueda, L. Ebah, A. Jayanti, D. Kanigicherla, A. Summers, G. Manley, G. Dutton, N. Chalmers, S. Mitra, I.-A. Checherita, A. Niculae, D. Radulescu, C. David, F. L. Turcu, A. Ciocalteu, V. Persic, J. Buturovic-Ponikvar, R. Ponikvar, M. Touam, V. Menoyo, T. Drueke, M. Rifaat, C. Muresan, M. Abtahi, Z. Koochakipour, D. Joly, J. Baharani, S. Rizvi, K. P. Ng, L. Buzzi, C. Sarcina, E. Alberghini, F. Ferrario, I. Baragetti, G. Santagostino, S. Furiani, E. Corghi, V. Terraneo, F. Rastelli, G. Bacchini, C. Pozzi, M. Adorati Menegato, R. Mortellaro, A. Locicero, A. Romano, P. P. Manzini, D. Steckiph, S. Shintaku, H. Kawanishi, M. Moriishi, M. Bansyodani, S. Nakamura, M. Saito, S. Tsuchiya, F. Barros, R. Vaz, B. Carvalho, P. Martins, E. Likaj, S. Seferi, M. Rroji, A. Idrizi, A. Duraku, M. Barbullushi, and N. Thereska
- Subjects
Transplantation ,Nephrology - Published
- 2013
- Full Text
- View/download PDF
7. Clinical studies in CKD 1-5
- Author
-
M. Szotowska, J. Chudek, A. Wiecek, M. Adamczak, M. Bossola, E. DI Stasio, M. Antocicco, P. Silvestri, L. Tazza, A. Stec, M. Koziol - Montewka, A. Ksiazek, K. Birnie, F. Caskey, A. I. Geeson, D. Dairaghi, D. Johnson, M. Leleti, S. Miao, H. Xiao, J. C. Jennette, J. P. Powers, L. Seitz, Y. Wang, J. C. Jaen, T. J. Schall, P. Bekker, H. Arai, H. Hayashi, K. Sugiyama, K. Yamamoto, S. Koide, K. Murakami, M. Tomita, M. Hasegawa, Y. Yuzawa, D. Karasavvidou, R. Kalaitzidis, G. Spanos, K. Pappas, A. Tatsioni, K. Siamopoulos, Y.-Y. Zhang, Z. Tang, D.-M. Chen, M.-C. Zhang, Z.-H. Liu, Y. Milovanov, L. Milovanova, L. Kozlovskaya, C. Klein, P. Noertersheuser, S. Mensing, N. Teuscher, C. Meyer, E. Dumas, W. Awni, H. Dezfoolian, O. Samuelsson, M. Svensson, Y. Yasuda, S. Kato, N. Tsuboi, W. Sato, S. Maruyama, E. Imai, S. Matsuo, P. Sarafidis, R. Blacklock, E. Wood, A. Rumjon, S. Simmonds, J. Fletcher-Rogers, R. Elias, B. Tucker, D. Baynes, C. Sharpe, K. Vinen, S. Hebbar, A. Goldsberry, M. Chin, and P. Audhya
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Medicine ,business ,Intensive care medicine - Published
- 2012
- Full Text
- View/download PDF
8. Cardiovascular complications in CKD 5D
- Author
-
M. Fusaro, M. Noale, G. Tripepi, A. D'angelo, D. Miozzo, M. Gallieni, P.-V. Study Group, M. Tsamelesvili, C. Dimitriadis, A. Papagianni, C. Raidis, G. Efstratiadis, D. Memmos, R. Mutluay, C. Konca Degertekin, U. Derici, S. M. Deger, F. Akkiyal, S. Gultekin, S. Gonen, G. Tacoy, T. Arinsoy, S. Sindel, C. Sanchez-Perales, E. Vazquez, E. Merino, P. Perez Del Barrio, F. J. Borrego, M. J. Borrego, A. Liebana, M. Krzanowski, K. Janda, P. Dumnicka, A. Krasniak, W. Sulowicz, Y.-O. Kim, S.-A. Yoon, Y.-S. Yun, H.-C. Song, B.-S. Kim, M. A. Cheong, A. Pasch, S. Farese, J. Floege, W. Jahnen-Dechent, T. Ohtake, R. Furuya, M. Iwagami, D. Tsutsumi, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, H. Moriya, S. Hidaka, S. Kobayashi, A. Guedes, A. Malho Guedes, A. Pinho, A. Fragoso, A. Cruz, P. Mendes, E. Morgado, I. Bexiga, A. P. Silva, P. Neves, N. Oyake, K. Suzuki, S. Itoh, S. Yano, K. Turkmen, H. Kayikcioglu, O. Ozbek, M. Saglam, A. Toker, H. Z. Tonbul, S. Gelev, L. Trajceska, E. Srbinovska, S. Pavleska, V. Amitov, G. Selim, P. Dzekova, A. Sikole, H. Bouarich, S. Lopez, C. Alvarez, I. Arribas, P. DE Sequera, D. Rodriguez, S. Tanaka, T. Kanemitsu, M. Sugahara, M. Kobayashi, L. Uchida, Y. Ishimoto, N. Kotera, S. Tanimoto, K. Tanabe, K. Hara, T. Sugimoto, N. Mise, B. Goldstein, M. Turakhia, C. Arce, W. Winkelmayer, B. E.-D. Zayed, K. Said, M. Nishimura, Y. Okamoto, T. Tokoro, M. Nishida, T. Hashimoto, N. Iwamoto, H. Takahashi, T. Ono, N. Sato, J. Raimann, L. A. Usvyat, J. Sands, N. W. Levin, P. Kotanko, M. Iwasaki, N. Joki, Y. Tanaka, N. Ikeda, T. Hayashi, S. Kubo, T.-A. Imamura, Y. Takahashi, K. Hirahata, Y. Imamura, H. Hase, K. Claes, B. Meijers, B. Bammens, D. Kuypers, M. Naesens, Y. Vanrenterghem, P. Evenepoel, G. Boscutti, L. Calabresi, M. Bosco, S. Simonelli, E. Boer, C. Vitali, M. Martone, P. L. Mattei, G. Franceschini, E. Baligh, E. El-Shafey, A. Ezaat, A. Zawada, K. Rogacev, B. Hummel, O. Grun, A. Friedrich, B. Rotter, P. Winter, J. Geisel, D. Fliser, G. H. Heine, J.-I. Makino, K.-S. Makino, T. Ito, S. Genovesi, A. Santoro, P. Fabbrini, E. Rossi, D. Pogliani, A. Stella, G. Bonforte, G. Remuzzi, S. Bertoli, C. Pozzi, S. Pasquali, L. Cagnoli, F. Conte, I. Buzadzic, J. Tosic, N. Dimkovic, Z. Djuric, J. Popovic, I. Pejin Grubisa, N. Barjaktarevic, A. DI Napoli, D. DI Lallo, M. F. Salvatori, F. Franco, S. Chicca, G. Guasticchi, M. Onofriescu, S. Hogas, V. Luminita, A. Mugurel, V. Gabriel, F. Laura, M. Irina, C. Adrian, E. Bosch, E. Baamonde, C. Culebras, G. Perez, B. El Hayek, J. I. Ramirez, A. Ramirez, C. Garcia, M. Lago, A. Toledo, M. D. Checa, T. Taira, T. Hirano, K. Nohtomi, T. Hyodo, T. Chiba, A. Saito, Y. K. Kim, E. J. Choi, C. W. Yang, Y.-S. Kim, P. S. Lim, W. Ming Ying, J. Ya-Chung, I. Zaripova, I. Kayukov, A. Essaian, A. Nimgirova, H. Young, M. Dungey, E. L. Watson, R. Baines, J. O. Burton, A. C. Smith, K. Yamazaki, M. Bossola, L. Colacicco, D. Scribano, C. Vulpio, L. Tazza, T. Okada, N. Okada, I. Michibata, T. Yura, N. Montero, M. Soler, M. Pascual, C. Barrios, E. Marquez, E. Rodriguez, M. A. Orfila, H. Cao, E. Arcos, J. Comas, J. Pascual, M. Ferrario, F. Garzotto, T. Sironi, S. Monacizzo, F. Basso, D. N. Cruz, U. Moissl, C. Tetta, M. G. Signorini, S. Cerutti, C. Ronco, I. Mostovaya, M. Grooteman, M. Van den Dorpel, L. Penne, N. Van der Weerd, A. Mazairac, C. Den Hoedt, R. Levesque, M. Nube, P. Ter Wee, M. Bots, P. Blankestijn, J. Liu, K. L. MA, X. Zhang, B. C. Liu, I.-D. Vladu, R. Mustafa, D. Cana-Ruiu, C. Vaduva, C. Grauntanu, E. Mota, R. Singh, N. Abbasian, C. Stover, N. Brunskill, J. Burton, K. Herbert, A. Bevington, M. Wu, R.-N. Tang, M. Gao, H. Liu, L. Chen, L.-L. LV, B.-C. Liu, M. Nikodimopoulou, S. Liakos, S. Kapoulas, C. Karvounis, D. Fedak, M. Kuzniewski, D. Paulina, B. Kusnierz-Cabala, M. Kapusta, B. Solnica, A. Junque, E. S. Vicent, L. Moreno, M. Fulquet, V. Duarte, A. Saurina, M. Pou, J. Macias, M. Lavado, M. Ramirez de Arellano, M. Ryuzaki, H. Nakamoto, S. Kinoshita, E. Kobayashi, C. Takimoto, T. Shishido, G. Enia, C. Torino, R. Tripepi, V. Panuccio, M. Postorino, A. Clementi, M. Garozzo, G. Bonanno, R. Boito, G. Natale, T. Cicchetti, A. Chippari, D. Logozzo, G. Alati, S. Cassani, A. Sellaro, C. Zoccali, B. Quiroga, E. Verde, S. Abad, A. Vega, M. Goicoechea, J. Reque, J. M. Lopez-Gomez, J. Luno, C. Cabre Menendez, V. Moles, J. P. Vives, D. Villa, J. Vinas, T. Compte, M. Arruche, C. Diaz, J. Soler, J. Aguilera, A. Martinez Vea, A. De Mauri, P. David, M. M. Conte, D. Chiarinotti, C. E. Ruva, M. De Leo, A.-S. Bargnoux, M. Morena, I. Jaussent, L. Chalabi, P. Bories, J.-J. Dion, P. Henri, M. Delage, A.-M. Dupuy, S. Badiou, B. Canaud, J.-P. Cristol, E. Sironi, F. Pieruzzi, E. Galbiati, M. R. Vigano, S. Anpalakhan, S. Rocha, N. Chitalia, R. Sharma, J. C. Kaski, J. Chambers, D. Goldsmith, D. Banerjee, V. Cernaro, A. Lacquaniti, R. Lupica, S. Lucisano, M. R. Fazio, V. Donato, M. Buemi, I. Segalen, U. Vinsonneau, T. Tanquerel, G. Quiniou, Y. Le Meur, E. Seibert, M. Girndt, K. Zohles, C. Ulrich, A. Kluttig, S. Nuding, C. Swenne, J. Kors, K. Werdan, R. Fiedler, N. C. Van der Weerd, M. P. Grooteman, M. A. Van den Dorpel, M. J. Nube, J. Wetzels, D. W. Swinkels, P. M. Ter Wee, A. Khandekar, J. Khandge, J. E. Lee, S. J. Moon, K. H. Choi, H. Y. Lee, B. S. Kim, E. Tuaillon, A. Rodriguez, L. Chenine, J.-P. Vendrell, Y.-M. Sue, C.-H. Tang, Y.-C. Chen, P. Segura, M. J. Garcia Cortes, J. M. Gil, M. M. Biechy, D. Poulikakos, A. Shah, M. Persson, P. Dattolo, M. Amidone, S. Michelassi, L. Moriconi, G. Betti, P. Conti, A. Rosati, A. Mannarino, V. Panichi, F. Pizzarelli, K. Klejna, B. Naumnik, E. Koc-Zorawska, M. Mysliwiec, S. Dimitrie, H. Simona, O. Mihaela, O. Gabriela, S. Radu, P. Octavian, H. Akdam, H. Akar, Y. Yenicerioglu, O. Kucuk, I. Kurt Omurlu, S. Thambiah, R. Roplekar, P. Manghat, I. Fogelman, W. Fraser, G. Hampson, E. Likaj, G. Caco, S. Seferi, M. Rroji, M. Barbullushi, N. Thereska, A. Serban, V. Carmen, S. Cristian, L. Silvia, and A. Covic
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,medicine ,Intensive care medicine ,business - Published
- 2012
- Full Text
- View/download PDF
9. [When the native arterial-venous fistula cannot be performed: graft or catheter? A comment]
- Author
-
L, Tazza and F, Galli
- Subjects
Arteriovenous Shunt, Surgical ,Catheters, Indwelling ,Renal Dialysis ,Humans ,Blood Vessel Prosthesis - Abstract
In Italy, the logistics for the creation of a vascular access are not well arranged. Numerous specialists are involved, mostly on a voluntary basis: they are those who ''know how to make the vascular access'', and have earned the title on the battlefield. When a native arteriovenous fistula, the gold standard, cannot be created, different solutions may prevail, depending on the local availability of specific skills. The use of vascular grafts for vascular access is not common in Italy. Grafts are mainly performed by vascular surgeons or, less frequently, by nephrologists with specific expertise in centers of excellence. By contrast, venous catheterization as an emergency access for dialysis is very common in Italian nephrology and dialysis centers. In optimal operating conditions, when both options are available and fistula creation and management are feasible, the choice of a graft fistula would be almost obligatory, although there are exceptions. Usually, the need urges the renal physician to favor compromise solutions: a compromise between physician and patient, between who performs the vascular access and who manages dialysis, between the patient's right to express a choice and acute disease that requires a quick solution and positive outcome. We need a revision (or revolution?) of vascular access creation and management that will lead to a choice between venous catheter or vascular graft that is balanced and useful for the patient.
- Published
- 2009
10. Which is the easiest and safest technique for central venous access? A retrospective survey of more than 5,400 cases
- Author
-
M. Pittiruti, M. Buononato, M. Malerba, C. Carriero, L. Tazza, and D. Gui
- Subjects
medicine.medical_specialty ,Venipuncture ,Percutaneous ,business.industry ,030232 urology & nephrology ,Femoral vein ,030204 cardiovascular system & hematology ,medicine.disease ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Pneumothorax ,Nephrology ,Jugular vein ,cardiovascular system ,medicine ,business ,Internal jugular vein ,Subclavian vein ,External jugular vein - Abstract
There is an ongoing debate on the technique for central venous catheterization associated with the lowest complication rate and the highest success rate. In an attempt to better define the easiest and safest venous approach, we have reviewed our 7-year experience with 5479 central venous percutaneous punctures (by Seldinger's technique) for the insertion of short-term (n=2109), medium/long-term (n=2627) catheters, as well as double-lumen, large-bore catheters for hemodialysis and/or hemapheresis (n=743). We have analyzed the incidence of the most frequent insertion-related complications by comparing seven different venous approaches: jugular vein, low lateral approach; jugular vein, high lateral approach; jugular vein, low axial approach; subclavian vein, infraclavicular approach; subclavian vein, supraclavicular approach; external jugular vein; femoral vein. The results of our retrospective study suggest that the ‘low lateral’ approach to the internal jugular vein, as described by Jernigan and modified according to our protocol, appears to be the easiest and safest technique for percutaneous insertion of central venous access, being characterized by the lowest incidence of accidental arterial puncture (1.2%) and malposition (0.8%), no pneumothorax, and an extremely low rate of repeated attempts (i.e. more than two punctures before successful cannulation) (3.3%). We advocate the ‘low lateral’ approach to the internal jugular vein as first-choice technique for venipuncture in both adults and children, for both short-term and long-term central venous percutaneous cannulation.
- Published
- 2007
11. Ureteral stent forgotten in renal transplanted patient. Its removal
- Author
-
M, Giustacchini, L, Tazza, M, Raguso, and G, Albino
- Subjects
Time Factors ,Anastomosis, Surgical ,Urinary Bladder ,Humans ,Female ,Stents ,Middle Aged ,Ureter ,Kidney Transplantation ,Device Removal - Abstract
The emblematic case of a forgotten ureteral stent in a renal transplanted patient is reported. The removal was performed with no more difficulties than in a not transplanted patient, but we would emphasize the importance of removing the stent when its function of protecting the anastomosis finished, but before its permanence could compromise the graft.
- Published
- 1999
12. Arterial injuries following diagnostic, therapeutic, and accidental arterial cannulation in haemodialysis patients
- Author
-
G Cina, G Viola, L Tazza, and M G De Rosa
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Arteriovenous fistula ,Pseudoaneurysm ,Renal Dialysis ,Catheterization, Peripheral ,medicine ,Humans ,Vein ,Dialysis ,Transplantation ,Vascular disease ,business.industry ,Middle Aged ,medicine.disease ,Aneurysm ,Surgery ,medicine.anatomical_structure ,Nephrology ,Arteriovenous Fistula ,Female ,Hemodialysis ,Complication ,business ,Artery - Abstract
Patients undergoing dialysis carry a high risk of Background. Incidence of iatrogenic arterial lesions is arterial lesions related to arterial cannulation for diacurrently increasing and patients undergoing dialysis gnostic or therapeutic procedures or to vascular access. represent a group at high risk since they require In the latter case, complications could be related to repeated cannulation of the vascular access and inter- the use of large calibre double-lumen central vein mittent heparinization during maintenance haemo- catheters for temporary dialysis or to repeated candialysis. nulation of a surgically created arteriovenous fistula. Clinical reports. Between 1992 and 1995 we treated In these patients at least three other factors increase four vascular lesions (two pseudoaneurysms and two the risk of complications: atherosclerosis, use of largearteriovenous fistulae) with surgery in three patients calibre venous catheters and systemic heparinization. undergoing dialysis at our centre. In the period between 1992 and 1995, we have treated No postoperative morbidity and mortality was with surgery four vascular lesions (two pseudoaneurobserved; in all cases surgery was eective. ysms, two arteriovenous fistulae) in three patients Conclusions. Although conservative treatment ( US undergoing dialysis at our Centre. Of these, three were guided compression) of arterial lesions shows promis- directly related to the use of a vascular access for ing results, in patients undergoing dialysis combined dialysis, one was shown to be secondary to cardiac with heparinization it seems less suitable. catheterization. In these patients, early detection of post-cannulation pseudoaneurysms or arteriovenous fistulae allows surgical treatment, with low morbidity rate and satisfactory long-term outcome. Clinical reports
- Published
- 1997
13. Extracorporeal dialysis: techniques and adequacy
- Author
-
C. Donadio, A. Kanaki, A. Martin-Gomez, S. Garcia, M. Palacios-Gomez, D. Calia, E. Colombini, F. DI Francesco, S. Ghimenti, M. Onor, D. Tognotti, R. Fuoco, E. Marka-Castro, M. I. Torres Zamora, J. Giron-Mino, M. A. Jaime-Solis, L. M. Arteaga, H. Romero, A. Akonur, K. Leypoldt, M. Asola, B. Culleton, S. Eloot, G. Glorieux, N. Nathalie, R. Vanholder, A. Perez de Jose, U. Verdalles Guzman, S. Abad Esttebanez, A. Vega Martinez, D. Barraca, C. Yuste, L. Bucalo, A. Rincon, J. M. Lopez-Gomez, P. Bataille, P. Celine, A. Raymond, G. Francois, L. Herve, D. Michel, R. Jean Louis, F. Zhu, P. Kotanko, S. Thijssen, N. W. Levin, N. Papamichail, M. Bougiakli, C. Gouva, S. Antoniou, S. Gianitsi, A. Vlachopanou, S. Chachalos, K. Naka, D. Kaarsavvidou, K. Katopodis, L. Michalis, K. Sasaki, K. Yasuda, M. Yamato, A. Surace, P. Rovatti, D. Steckiph, R. Bandini, S. Severi, A. Dellacasa Bellingegni, A. Santoro, M. Arias, A. Sentis, N. Perez, N. Fontsere, M. Vera, N. Rodriguez, C. Arcal, N. Ortega, F. Uriza, A. Cases, F. Maduell, S. R. Abbas, P. Georgianos, P. Sarafidis, P. Nikolaidis, A. Lasaridis, A. Ahmed, H. Kaoutar, B. Mohammed, O. Zouhir, P. Balter, N. Ginsberg, P. Taylor, T. Sullivan, L. A. Usvyat, P. Zabetakis, U. Moissl, M. Ferrario, F. Garzotto, P. Wabel, D. Cruz, C. Tetta, M. G. Signorini, S. Cerutti, A. Brendolan, C. Ronco, J. Heaf, M. Axelsen, R. S. Pedersen, H. Amine, Z. Oualim, A. L. Ammirati, N. K. Guimaraes de Souza, T. Nemoto Matsui, M. Luiz Vieira, W. A. Alves de Oliveira, C. H. Fischer, F. Dias Carneiro, I. J. Iizuka, M. Aparecida de Souza, A. C. Mallet, M. C. Cruz Andreoli, B. F. Cardoso Dos Santos, L. Rosales, Y. Dou, M. Carter, A. Testa, L. Sottini, B. Giacon, E. Prati, C. Loschiavo, M. Brognoli, C. Marseglia, A. Tommasi, L. Sereni, G. Palladino, S. Bove, G. Bosticardo, E. Schillaci, P. Detoma, R. Bergia, J. W. Park, S. J. Moon, H. Y. Choi, S. K. Ha, H.-C. Park, Y. Liao, L. Zhang, P. Fu, H. Igarashi, N. Suzuki, S. Esashi, I. Masakane, V. Panichi, G. De Ferrari, S. Saffiotti, A. Sidoti, M. Biagioli, S. Bianchi, P. Imperiali, C. Gabrielli, P. Conti, P. Patrone, G. Rombola, V. Falqui, C. Mura, A. Icardi, A. Rosati, F. Santori, A. Mannarino, A. Bertucci, J. Jeong, O. K. Kim, N. H. Kim, M. Bots, C. Den Hoedt, M. P. Grooteman, N. C. Van der Weerd, A. H. A. Mazairac, R. Levesque, P. M. Ter Wee, M. J. Nube, P. Blankestijn, M. A. Van den Dorpel, Y. Park, J. Jeon, N. Tessitore, V. Bedogna, D. Girelli, L. Corazza, P. Jacky, Q. Guillaume, B. Julien, W. Marcinkowski, M. Drozdz, A. Milkowski, T. Rydzynska, T. Prystacki, R. August, E. Benedyk-Lorens, K. Bladek, J. Cina, G. Janiszewska, A. Kaczmarek, T. Lewinska, M. Mendel, M. Paszkot, E. Trafidlo, M. Trzciniecka-Kloczkowska, A. Vasilevsky, G. Konoplev, O. Lopatenko, A. Komashnya, K. Visnevsky, R. Gerasimchuk, I. Neivelt, A. Frorip, M. Vostry, J. Racek, D. Rajdl, J. Eiselt, L. Malanova, U. Pechter, A. Selart, M. Ots-Rosenberg, D. H. Krieter, S. Seidel, K. Merget, H.-D. Lemke, C. Wanner, B. Canaud, A. Rodriguez, A. Morgenroth, K. Von Appen, G.-P. Dragoun, R. Fluck, D. Fouque, R. Lockridge, Y. Motomiya, Y. Uji, T. Hiramatsu, Y. Ando, M. Furuta, T. Kuragano, A. Kida, M. Yahiro, Y. Otaki, Y. Hasuike, H. Nonoguchi, T. Nakanishi, M. Sain, V. Kovacic, D. Ljutic, J. Radic, I. Jelicic, S. F. Yalin, S. Trabulus, A. S. Yalin, M. R. Altiparmak, K. Serdengecti, A. Ohtsuka, K. Fukami, K. Ishikawa, R. Ando, Y. Kaida, T. Adachi, K. Sugi, S. Okuda, O. B. Nesterova, E. D. Suglobova, R. V. Golubev, A. N. Vasiliev, V. A. Lazeba, A. V. Smirnov, K. Arita, E. Kihara, K. Maeda, H. Oda, S. Doi, T. Masaki, S. Hidaka, K. Ishioka, M. Oka, H. Moriya, T. Ohtake, S. Nomura, S. Kobayashi, S. Wagner, A. Gmerek, J. Wagner, V. Wizemann, N. Eftimovska - Otovic, K. Spaseska-Gjurovska, S. Bogdanovska, E. Babalj - Banskolieva, M. Milovanceva, R. Grozdanovski, A. Pisani, E. Riccio, A. Mancini, P. Ambuhl, S. Astrid, P. Ivana, H. Martin, K. Thomas, R. Hans-Rudolf, A. Daniel, K. Denes, M. Marco, R. P. Wuthrich, S. Andreas, S. Andrulli, P. Altieri, G. Sau, P. Bolasco, L. A. Pedrini, C. Basile, S. David, M. Feriani, P. E. Nebiolo, R. Ferrara, D. Casu, F. Logias, R. Tarchini, F. Cadinu, M. Passaghe, G. Fundoni, G. Villa, B. R. DI Iorio, C. Zoccali, F. Locatelli, M. Hamamoto, D.-Y. Lee, B. Kim, K. H. Moon, Z. LI, P. Ahrenholz, R. E. Winkler, G. Waitz, H. Wolf, G. Grundstrom, M. Alquist, M. Holmquist, A. Christensson, P. Bjork, M. Abdgawad, L. Ekholm, M. Segelmark, C. Corsi, J. De Bie, E. Mambelli, D. Mortara, D. Arroyo, N. Panizo, B. Quiroga, J. Reque, R. Melero, M. Rodriguez-Ferrero, P. Rodriguez-Benitez, F. Anaya, J. Luno, A. Ragon, A. James, P. Brunet, S. Ribeiro, M. S. Faria, S. Rocha, S. Rodrigues, C. Catarino, F. Reis, H. Nascimento, J. Fernandes, V. Miranda, A. Quintanilha, L. Belo, E. Costa, A. Santos-Silva, J. Arund, R. Tanner, I. Fridolin, M. Luman, C. Clajus, J. T. Kielstein, H. Haller, P. Libutti, P. Lisi, L. Vernaglione, F. Casucci, N. Losurdo, A. Teutonico, C. Lomonte, C. Krisp, D. A. Wolters, M. Matsuyama, T. Tomo, K. Ishida, K. Matsuyama, T. Nakata, J. Kadota, M. Caiazzo, E. Monari, A. Cuoghi, E. Bellei, S. Bergamini, A. Tomasi, T. Baranger, P. Seniuta, F. Berge, V. Drouillat, C. Frangie, E. Rosier, W. Labonia, A. Lescano, D. Rubio, N. Von der Lippe, J. A. Jorgensen, T. B. Osthus, B. Waldum, I. Os, M. Bossola, E. DI Stasio, M. Antocicco, L. Tazza, I. Griveas, A. Karameris, P. Pasadakis, V. Savica, D. Santoro, S. Saitta, V. Tigano, G. Bellinghieri, S. Gangemi, R. Daniela, I. A. Checherita, A. Ciocalteu, I. A. Vacaroiu, A. Niculae, E. Stefaniak, I. Pietrzak, D. Krupa, L. Garred, E. Mancini, L. Corrazza, M. Atti, B. Afsar, D. Stamopoulos, N. Mpakirtzi, B. Gogola, M. Zeibekis, D. Stivarou, M. Panagiotou, E. Grapsa, O. Vega Vega, D. Barraca Nunez, M. Fernandez-Lucas, A. Gomis, J. L. Teruel, S. Elias, C. Quereda, L. Hignell, S. Humphrey, N. Pacy, and N. Afentakis
- Subjects
Transplantation ,medicine.medical_specialty ,Extracorporeal Dialysis ,Nephrology ,business.industry ,Uremic toxins ,Medicine ,Identification (biology) ,business ,Intensive care medicine ,Microbiology - Published
- 2011
- Full Text
- View/download PDF
14. Foot alterations in the hemodialyzed patient
- Author
-
L, de Palma, F, Serra, V, Coletti, and L, Tazza
- Subjects
Chronic Kidney Disease-Mineral and Bone Disorder ,Foot Diseases ,Male ,Radiography ,Foot ,Foot Deformities, Acquired ,Renal Dialysis ,Humans ,Female ,Middle Aged - Abstract
On the basis of their experience, the authors refer to complications observable at the foot level in chronic uremic patients in long-term hemodialytic treatment. These complications, termed renal osteodystrophy, are attributed to alterations in the phosphocalcium metabolism and to hyperparathyroidism. From an anatomopathologic viewpoint, they are characterized by alteration in bone tissue (osteomalacia and/or fibrous osteitis) and by soft tissue alterations. Alterations in the foot are the same as those observed in other osteoarticular regions. They consist of bone subperiosteal reabsorption of the phalanges, vascular calcifications, articular and para-articular calcifications, spontaneous disinsertion of the Achilles tendon and peripheral canalicular neuropathies specifically represented by the tarsal tunnel syndrome. Another complication of this pathology is represented by "Calciphylaxis," characterized by calcifications of the middle tunica of arteries and small arteries, by ulcerations and tissue necrosis at the foot level.
- Published
- 1993
15. [Abdominal lesions associated with splenic injury: prognostic significance]
- Author
-
P L, Bonatti, F, Caracciolo, S, Bonventre, L, Tazza, G, Castrucci, and F, Citterio
- Subjects
Athletic Injuries ,Accidents, Traffic ,Splenectomy ,Humans ,Abdominal Injuries ,Splenic Rupture ,Prognosis ,Wounds, Nonpenetrating - Published
- 1983
16. [Results of the surgical treatment of primary hyperparathyroidism]
- Author
-
G, Castrucci, L, Alimandi, F, Caracciolo, L, Castrucci, and L, Tazza
- Subjects
Adenoma ,Adult ,Parathyroid Neoplasms ,Hyperparathyroidism ,Humans ,Female ,Middle Aged - Published
- 1983
17. [Ingestion of potassium permanganate: a rare indication for emergency surgery]
- Author
-
L, Tazza, G, Castrucci, A, Borzone, and F, Caracciolo
- Subjects
Laparotomy ,Jejunum ,Potassium Permanganate ,Humans ,Female ,Emergencies ,Middle Aged ,Gastric Lavage - Published
- 1982
18. [Our experience in the surgical treatment of hyperparathyroidism secondary to chronic renal insufficiency]
- Author
-
G, Castrucci, L, Tazza, G, Luciani, C, Destito, and F, Caracciolo
- Subjects
Adult ,Male ,Parathyroid Glands ,Humans ,Kidney Failure, Chronic ,Female ,Hyperparathyroidism, Secondary - Published
- 1982
19. [Pseudolymphoma of the lung]
- Author
-
L, Tazza, C, Destito, A, Destito, and A, Wiel Marin
- Subjects
Adult ,Radiography ,Lung Neoplasms ,Lymphoma ,Humans ,Female ,Lymphocytes - Published
- 1983
20. Vascular access for hemodialysis in Italy: What a national survey reveals.
- Author
-
Napoli M, Guzzi F, Morale W, Lomonte C, Galli F, Lodi M, Bonforte G, Bonucchi D, Brunori G, Buzzi L, Forneris G, Gallieni M, Meola M, Pirozzi N, Sessa C, Spina M, and Tazza L
- Abstract
Background: Since in Italy there are no official data on vascular access (VA) for hemodialysis the Vascular Access Project Group (VAPG) of the Italian Society of Nephrology (SIN) designed a national survey., Methods: A 35-question survey was designed and sent it to the Italian facilities through the SIN website. The basic questions were the prevalence, the location, and the surveillance of VA, the bedside use of ultrasound, the use of fluoroscopy for central venous catheter (CVC) placement, and of buttonhole technique, the role of nephrologist in the access creation., Result: The questionnaire was completed in June 2022 by 161 facilities. The survey registered 15,499 patients, approximately one-third of the Italian dialysis population. The prevalence of arteriovenous fistula (AVF), arteriovenous Graft (AVG), and CVC were 61.8%, 3.7%, and 34.5% respectively. The AVF location was 50% in distal forearm, 20% in meanproximal forearm, 30% in upper arm. For AVF creation, nephrologists were involved in 72% of facilities while for CVC placement in 62%. As regards VA monitoring, 21% of the facilities did not have a surveillance protocol; 60% did not register AVF thrombosis and 53% did not register CVC infections. Most of facilities use the fluoroscope during CVC placement, 37% when needed, and 22% never. Ultrasound-guided puncture of complex AVFs was used by 80% of facilities. Buttonhole puncture was used in 5% of patients., Conclusions: Some considerations emerge from the survey data: (1) The increasing CVC prevalence compared to DOPPS 5 study. (2) The low rate of AVG prevalence. (3) The nephrologist is the operator in many VA procedures. (4) The fluoroscopy for CVC placement and the US-guide puncture of the complex AVF are widely used in most facilities. (5) The practice of the buttonhole is not widespread. (6) When the operator is the nephrologist more distal fistulas are performed., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
21. Gender Disparities in Vascular Access and One-Year Mortality among Incident Hemodialysis Patients: An Epidemiological Study in Lazio Region, Italy.
- Author
-
Angelici L, Marino C, Umbro I, Bossola M, Calandrini E, Tazza L, Agabiti N, Davoli M, and On Behalf Of The Regional Registry Dialysis And Transplant Lazio Region
- Abstract
(1) Background: Interest in gender disparities in epidemiology, clinical features, prognosis and health care in chronic kidney disease patients is increasing. Aims of the study were to evaluate the association between gender and vascular access (arteriovenous fistula (AVF) or central venous catheter (CVC)) used at the start of hemodialysis (HD) and to investigate the association between gender and 1-year mortality. (2) Methods: The study includes 9068 adult chronic HD patients (64.7% males) registered in the Lazio Regional Dialysis Register (January 2008-December 2018). Multivariable logistic regression models were used to investigate the associations between gender and type of vascular access (AVF vs. CVC) and between gender and 1-year mortality. Interactions between gender and socio-demographic and clinical variables were tested adding the interaction terms in the final model. (3) Results: Females were older, had lower educational level and lower rate of self-sufficiency compared to males. Overall, CVC was used in 51.2% of patients. Females were less likely to use AVF for HD initiation than males. 1354 out of 8215 (16.5%) individuals died at the end of the follow-up period. Interaction term between gender and vascular access was significant in the adjusted model. From stratified analyses by vascular access, OR female vs. male (AVF) = 0.65; 95% CI 0.48-0.87 and OR female vs. male (CVC) = 0.88; 95% CI 0.75-1.04 were found. (4) Conclusions: This prospective population-based cohort study in a large Italian Region showed that in females starting chronic HD AVF was less common respect to men. The better 1-year survival of females is more evident among those women with AVF. Reducing gender disparity in access to AVF represents a key point in the management of HD patients.
- Published
- 2021
- Full Text
- View/download PDF
22. Determinants of venous catheter hemodialysis onset and subsequent switch to arteriovenous fistula: An epidemiological study in Lazio region.
- Author
-
Tazza L, Angelici L, Marino C, Di Napoli A, Bossola M, De Cicco C, Davoli M, and Agabiti N
- Subjects
- Cohort Studies, Humans, Male, Renal Dialysis, Arteriovenous Fistula, Arteriovenous Shunt, Surgical adverse effects, Central Venous Catheters, Kidney Failure, Chronic diagnosis, Kidney Failure, Chronic epidemiology, Kidney Failure, Chronic therapy
- Abstract
Background: The factors associated with the inability to start hemodialysis with an arteriovenous fistula (AVF) in chronic kidney disease patients are not fully understood., Aim: Evaluating factors associated with type of vascular access at the first chronic hemodialysis and at 1 year after it., Methods: The study cohort includes patients registered in the Regional Dialysis and Transplant Registry of Lazio undergoing first hemodialysis between 2008 and 2015. Logistic regression models were used to evaluate the association between socio-demographic, clinical and care/organizational factors, and vascular access at first hemodialysis. Cox regression models were used to assess the odds of switching to AVF during the first year of hemodialysis among patients starting dialysis with central venous catheter (CVC)., Results: In the cohort of 6208 incident hemodialysis patients, 52.7% had an AVF and 47.3% had a CVC. Among the 2939 incident patients with CVC, 27.4% switched to FAV after 1 year. A higher probability of starting dialysis with AVF was observed among males (OR = 1.83; 95% CI 1.63-2.06), while a lower probability was observed among patients aged >85 years (OR 0.64; IC 95% 0.51-0.80). Patients with early referral to a nephrologist had a triple probability of start dialysis with AVF. We observed a higher odds of switch to AVF among males (HR = 1.62; 95% CI 1.40-1.89) and a lower odds among patients over 65 years., Conclusion: The observed high rate of AVF at the start of hemodialysis and of the switch from CVC to AVF in the first year, although declining since 2008, is a positive outcome. However, over one-third of patients maintain the CVC as vascular access for the first year because of unmodifiable factors, such as gender, age, comorbidity. The present study suggests that logistics/management and assistance/welfare problems may contribute to the delay or lack of AVF placement in incident hemodialysis patients or within the first year of dialysis.
- Published
- 2021
- Full Text
- View/download PDF
23. Functional impairment and risk of mortality in patients on chronic hemodialysis: results of the Lazio Dialysis Registry.
- Author
-
Bossola M, Marino C, Di Napoli A, Agabiti N, Tazza L, and Davoli M
- Subjects
- Activities of Daily Living, Aged, Aged, 80 and over, Female, Humans, Italy epidemiology, Kaplan-Meier Estimate, Male, Middle Aged, Proportional Hazards Models, Registries, Risk Factors, Survival Rate, Health Status, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Renal Dialysis statistics & numerical data
- Abstract
Background: Functional impairment is associated with adverse outcomes in older people, as well as in patients on chronic hemodialysis. The aim of this study was to evaluate if functional impairment represents a risk factor for reduced survival in patients on chronic hemodialysis., Methods: All incident chronic hemodialysis patients of Lazio, a large region of central Italy, registered in the Dialysis and Transplant Lazio Region Registry (DTLRR) in the period 2008-2013 were considered eligible. Inclusion criteria were: age > 18 years, resident in Lazio, still doing dialysis after 90 days from incidence date, doing hemodialysis or hemodiafiltration treatment for > 9 h/week. Patients were stratified into three classes of functional activity: total autonomy, autonomy in some activities, and not self-sufficient. Functional activity was assessed for each patient by the referring physician for the DTLRR from the ~ 90 hemodialysis units of the Lazio region. Each patient was followed from date of first dialysis treatment to the end of the study (31/12/2015) or death or renal transplant, whichever occurred first. Cox proportional hazard models were performed to obtain mortality hazard ratios (HR), 95% confidence intervals (CI), for each class of functional activity adjusting for sex, age, country of birth, city of residence, body mass index (BMI), type of nephropathy, vascular access, previous nephrology counselling, weekly hours of hemodialysis, serum albumin, hemoglobin, and presence of comorbidities (e.g. vascular diseases, coronary disease, and diabetes)., Results: A total of 3356 patients were studied. In the whole follow-up period, 1622 deaths occurred (48%). Functional impairment was associated with the risk of mortality: compared to 'total autonomy', the HR for 'autonomy in some activities' was 1.30 [95% CI: 1.14-1.49] and for 'not self-sufficient' 1.71 [1.47-1.99] (p for trend < 0.05). The number of evitable deaths attributable to reduced functional activity was 237., Conclusion: Functional impairment represents a risk factor for reduced survival in chronic hemodialysis patients. There is a need for early identification of patients who might benefit from interventions aimed at preventing, reversing or delaying the functional impairment.
- Published
- 2018
- Full Text
- View/download PDF
24. Survey on advance care planning of Italian outpatients on chronic haemodialysis.
- Author
-
Panocchia N, Tonnara G, Minacori R, Sacchini D, Bossola M, Tazza L, Gambaro G, and Spagnolo AG
- Subjects
- Aged, Decision Making, Female, Humans, Italy, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Terminal Care, Advance Care Planning, Health Knowledge, Attitudes, Practice, Outpatients psychology, Renal Dialysis psychology
- Abstract
Objectives: The clinical practice guidelines published by the Renal Physicians Association (USA) recommend instituting advance care planning (ACP) for patients with end-stage renal disease. Studies on this issue are lacking in Italy. Our aim was to determine the attitudes of patients on ACP in our dialysis centre., Methods: We performed a cross-sectional survey. We recruited patients on maintenance haemodialysis (HD) at Hemodialysis Center of Università Cattolica del Sacro Cuore, from 1 March 2014 to 31 March 2015. The only exclusion criterion was inability to give an informed consent. Patients completed a questionnaire concerning their treatment preferences in three hypothetical disease scenarios: persistent vegetative state, advanced dementia, severe terminal illness; for each patients, we also collected clinical, functional and socioeconomic data., Results: Thirty-four HD outpatients completed the study questionnaire. The majority of respondents (85%) considered information about prognosis, health conditions and treatment options, including withdrawing dialysis, as very important and 94% of respondents considered treatment of uraemic/dialytic symptoms the most important issue. In the health scenarios provided, dialysis was the treatment least withheld. Dependence on instrumental activities of daily living (0.048) and higher Charlson Comorbidity Index scores (p = 0.035) were associated with continuing dialysis in at least one scenario., Conclusions: ACP should be tailored to patients' value, culture and preferences. A significant proportion of patients, however, do not want to be involved in end of life decisions. Frail elderly patients, in particular, are not inclined to interrupt dialysis, despite poor quality of life or a poor prognosis., Competing Interests: Competing interests: None declared., (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
- Published
- 2017
- Full Text
- View/download PDF
25. Erratum to: The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology.
- Author
-
Lomonte C, Forneris G, Gallieni M, Tazza L, Meola M, Lodi M, Senatore M, Morale W, Spina M, Napoli M, Bonucchi D, and Galli F
- Published
- 2017
- Full Text
- View/download PDF
26. Clinical use of computational modeling for surgical planning of arteriovenous fistula for hemodialysis.
- Author
-
Bozzetto M, Rota S, Vigo V, Casucci F, Lomonte C, Morale W, Senatore M, Tazza L, Lodi M, Remuzzi G, and Remuzzi A
- Subjects
- Adult, Aged, Arteriovenous Shunt, Surgical adverse effects, Arteriovenous Shunt, Surgical standards, Female, Humans, Male, Middle Aged, Models, Theoretical, Arteriovenous Shunt, Surgical methods, Postoperative Complications prevention & control, Renal Dialysis methods
- Abstract
Background: Autogenous arteriovenous fistula (AVF) is the best vascular access (VA) for hemodialysis, but its creation is still a critical procedure. Physical examination, vascular mapping and doppler ultrasound (DUS) evaluation are recommended for AVF planning, but they can not provide direct indication on AVF outcome. We recently developed and validated in a clinical trial a patient-specific computational model to predict pre-operatively the blood flow volume (BFV) in AVF for different surgical configuration on the basis of demographic, clinical and DUS data. In the present investigation we tested power of prediction and usability of the computational model in routine clinical setting., Methods: We developed a web-based system (AVF.SIM) that integrates the computational model in a single procedure, including data collection and transfer, simulation management and data storage. A usability test on observational data was designed to compare predicted vs. measured BFV and evaluate the acceptance of the system in the clinical setting. Six Italian nephrology units were involved in the evaluation for a 6-month period that included all incident dialysis patients with indication for AVF surgery., Results: Out of the 74 patients, complete data from 60 patients were included in the final dataset. Predicted brachial BFV at 40 days after surgery showed a good correlation with measured values (in average 787 ± 306 vs. 751 ± 267 mL/min, R = 0.81, p < 0.001). For distal AVFs the mean difference (±SD) between predicted vs. measured BFV was -2.0 ± 20.9%, with 50% of predicted values in the range of 86-121% of measured BFV. Feedbacks provided by clinicians indicate that AVF.SIM is easy to use and well accepted in clinical routine, with limited additional workload., Conclusions: Clinical use of computational modeling for AVF surgical planning can help the surgeon to select the best surgical strategy, reducing AVF early failures and complications. This approach allows individualization of VA care, with the aim to reduce the costs associated with VA dysfunction, and to improve AVF clinical outcome.
- Published
- 2017
- Full Text
- View/download PDF
27. Functional impairment is associated with an increased risk of mortality in patients on chronic hemodialysis.
- Author
-
Bossola M, Di Stasio E, Antocicco M, Pepe G, Tazza L, Zuccalà G, and Laudisio A
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Geriatric Assessment, Humans, Male, Middle Aged, Prospective Studies, Renal Insufficiency, Chronic physiopathology, Risk Factors, Rome epidemiology, Surveys and Questionnaires, Survival Rate, Activities of Daily Living psychology, Depression epidemiology, Renal Dialysis psychology, Renal Insufficiency, Chronic mortality, Renal Insufficiency, Chronic therapy
- Abstract
Background: Functional impairment is associated with adverse outcomes in older people, as well as in patients on chronic hemodialysis. The aim of the present study was to determine the characteristics associated with functional impairment in chronic hemodialysis, and to evaluate if functional impairment represents a risk factor for reduced survival in chronic hemodialysis., Methods: All 132 chronic hemodialysis referring to the Hemodialysis Service of the Catholic University, Rome, Italy between November 2007 and May 2015 were included. All patients underwent comprehensive geriatric assessment; functional ability was estimated using two questionnaires exploring independency in bathing, dressing, toileting, transferring, continence, feeding (ADLs), and independency in using the telephone, shopping, food preparation, housekeeping, laundering, traveling, taking medications, and handling finances (IADLs). Functional impairment was diagnosed in presence of dependence in one or more ADLs/IADLs. Mood was assessed using the 30-item Geriatric Depression Scale. Logistic regression was used to evaluate factors associated with functional impairment. The association between functional impairment and survival was assessed by Cox regression., Results: ADLs impairment was present in 34 (26 %) participants, while IADLs impairment was detected in 64 (48 %) subjects. After a follow up of 90 months, 55 (42 %) patients died. In logistic regression, depressive symptoms were associated with ADLs and IADLs impairment (OR 1.12; 95 % CI = 1.02-1.23; OR 1.16; 95 % CI = 1.02-1.33; respectively). In Cox regression, ADLs impairment was associated with mortality (HR 2.47; 95 % CI-1.07-5.67) while IADLs impairment was not associated with reduced survival (HR .80; 95 % CI-.36-1.76)., Conclusions: Functional impairment is associated with depressive symptoms; also, impairment in the ADLs represents a risk factor of reduced survival in chronic hemodialysis. These associations and their potential implication should be assessed in dedicated studies.
- Published
- 2016
- Full Text
- View/download PDF
28. Postdialysis Fatigue: A Frequent and Debilitating Symptom.
- Author
-
Bossola M and Tazza L
- Subjects
- Fatigue therapy, Humans, Fatigue etiology, Quality of Life, Renal Dialysis adverse effects
- Abstract
Postdialysis fatigue (PDF) is a frequent and debilitating symptom of patients on chronic hemodialysis that affects their daily living and quality of life. Little is known about the mechanisms underlying this symptom and its severity. Only a few studies have investigated therapeutic interventions and with conflicting results. Given the major impact of PDF on the quality of life of hemodialysis patients, a larger effort is warranted to better understand, prevent, and treat PDF., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
29. The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology.
- Author
-
Lomonte C, Forneris G, Gallieni M, Tazza L, Meola M, Lodi M, Senatore M, Morale W, Spina M, Napoli M, Bonucchi D, and Galli F
- Subjects
- Age Factors, Arteriovenous Shunt, Surgical adverse effects, Catheterization, Central Venous adverse effects, Comorbidity, Consensus, Disease Progression, Humans, Italy, Patient Selection, Renal Dialysis adverse effects, Renal Insufficiency, Chronic diagnosis, Renal Insufficiency, Chronic epidemiology, Renal Insufficiency, Chronic physiopathology, Risk Factors, Time-to-Treatment, Treatment Outcome, Arteriovenous Shunt, Surgical standards, Catheterization, Central Venous standards, Nephrology standards, Renal Dialysis standards, Renal Insufficiency, Chronic therapy, Societies, Medical standards
- Abstract
The incident hemodialysis (HD) population is aging, and the elderly group is the one with the most rapid increase. In this context it is important to define the factors associated with outcomes in elderly patients. The high prevalence of comorbidities, particularly diabetes mellitus, peripheral vascular disease and congestive heart failure, usually make vascular access (VA) creation more difficult. Furthermore, many of these patients may have an insufficient vasculature for fistula maturation. Finally, many fistulas may never be used due to the competing risk of death before dialysis initiation. In these cases, an arteriovenous graft and in some cases a central venous catheter become a valid alternative form of VA. Nephrologists need to know what is the most appropriate VA option in these patients. Age should not be a limiting factor when determining candidacy for arteriovenous fistula creation. The aim of this position statement, prepared by experts of the Vascular Access Working Group of the Italian Society of Nephrology, is to critically review the current evidence on VA in elderly HD patients. To this end, relevant clinical studies and recent guidelines on VA are reviewed and commented. The main advantages and potential drawbacks of the different VA modalities in the elderly patients are discussed.
- Published
- 2016
- Full Text
- View/download PDF
30. Mortality in hospitalized chronic kidney disease patients starting unplanned urgent haemodialysis.
- Author
-
Panocchia N, Tazza L, Di Stasio E, Liberatori M, Vulpio C, Giungi S, Lucani G, Antocicco M, and Bossola M
- Subjects
- Age Factors, Aged, Aged, 80 and over, Chi-Square Distribution, Comorbidity, Female, Hospitals, University, Humans, Kaplan-Meier Estimate, Logistic Models, Longitudinal Studies, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Prospective Studies, Renal Dialysis adverse effects, Renal Insufficiency, Chronic diagnosis, Risk Assessment, Risk Factors, Rome, Tertiary Care Centers, Time Factors, Treatment Outcome, Hospital Mortality, Hospitalization, Renal Dialysis mortality, Renal Insufficiency, Chronic mortality, Renal Insufficiency, Chronic therapy
- Abstract
Aim: Data on the outcome of chronic kidney disease (CKD) patients who are hospitalized and start unplanned urgent haemodialysis (HD) are lacking. This prospective, longitudinal, observational study aimed to define the hospital mortality rate and associated factors in CKD patients who start unplanned urgent HD., Methods: Between January 2003 and December 2009, all patients with CKD who were hospitalized, diagnosed with ESRD and started unplanned urgent haemodialysis at Haemodialysis Service of the Catholic University of Rome, Italy were recruited. Exclusion criteria were: acute renal failure, prior history of dialysis, multiple organ failure, coma, and dementia. Hospital mortality rate was the primary outcome., Results: Three and hundred sixteen patients were studied: 99 died after 19.5 ± 27.3 days and 217 survived until discharge. Of these, 154 were prescribed chronic HD and 63 restored renal function. Patients who died were significantly older and had a higher Charlson Comorbidity Index score. The mortality rates were 51.1% in patients with 81-90 years, 37.8% with 71-80 years, 34.1% with 61-70 years and 13.9% with age ≤60 years. Logistic regression analysis showed that age only was an independent risk factor for all-cause mortality., Conclusions: In CKD patients who need hospitalization and start unplanned urgent haemodialysis the mortality is very high and significantly related to age., (© 2015 Asian Pacific Society of Nephrology.)
- Published
- 2016
- Full Text
- View/download PDF
31. Fatigue and plasma tryptophan levels in patients on chronic hemodialysis.
- Author
-
Bossola M and Tazza L
- Subjects
- Humans, Fatigue etiology, Fatigue therapy, Renal Insufficiency, Chronic complications
- Published
- 2015
- Full Text
- View/download PDF
32. Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients.
- Author
-
Bossola M and Tazza L
- Subjects
- Humans, Kidney Failure, Chronic complications, Risk Factors, Cardiovascular Diseases etiology, Kidney Failure, Chronic therapy, Oxidative Stress, Renal Dialysis adverse effects
- Abstract
The increased frequency of cardiovascular disease observed in hemodialysis patients is secondary to the combination of many traditional (age, male sex, hypertension, smoking, diabetes mellitus, and dyslipidemia) and novel and uremia-related (inflammation, uremic toxins, adipokine imbalance, coagulation disorders, protein-energy wasting, volume overload, endothelial dysfunction, hyperparathyroidism, and subclinical hypothyroidism) risk factors. Usually, in the latter group, oxidative stress is included. However, after decades of research, it remains essentially unknown if oxidative stress has a causative role in the development of cardiovascular disease in long-term hemodialysis patients because adequate longitudinal studies are lacking. Data deriving from cross-sectional studies suggest that biomarkers of oxidative stress are associated with cardiovascular disease prevalence. Conversely, conflicting and inconclusive results have been obtained on the association between oxidative stress and coronary artery calcification, atherosclerosis, and all-cause and cardiovascular disease-related outcome. It is desirable that further studies are conducted on this topic in the near future., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
33. Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis.
- Author
-
Bossola M, Di Stasio E, Giungi S, Rosa F, and Tazza L
- Subjects
- Aged, Comorbidity, Cross-Sectional Studies, Depression complications, Enzyme-Linked Immunosorbent Assay, Fatigue complications, Female, Humans, Kidney Failure, Chronic complications, Kidney Failure, Chronic immunology, Linear Models, Male, Middle Aged, Multivariate Analysis, Neuropsychological Tests, Psychiatric Status Rating Scales, Depression blood, Fatigue blood, Interleukin-6 blood, Kidney Failure, Chronic blood, Kidney Failure, Chronic therapy, Renal Dialysis
- Abstract
Context: Little is known about activated immune-inflammatory pathways and interleukin-6 (IL-6) in the development of fatigue and/or depression in patients with end-stage renal disease on chronic hemodialysis (HD)., Objectives: To evaluate the possible correlation between fatigue and serum levels of IL-6 in patients on chronic HD., Methods: One hundred HD patients were assessed for the presence of fatigue using the SF-36 Vitality subscale and were administered the Beck Depression Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), the Mini-Mental State Examination (MMSE), the activities of daily living (ADL), and the instrumental activities of daily living (IADL). We also calculated the time of recovery after hemodialysis (TIRD) and the number/severity of comorbidities using the Charlson Comorbidity Index (CCI). Laboratory parameters were measured as well as serum IL-6., Results: Forty-three patients constituted the fatigued group and 57 the nonfatigued group. Age, CCI, BDI, HARS, and TIRD were significantly higher in fatigued patients than in the nonfatigued patients. Conversely, the scores of ADL, IADL, and MMSE were significantly lower in fatigued than in nonfatigued patients. Serum IL-6 levels (pg/mL) were higher in the fatigued group (5.1 ± 3.4) than in the nonfatigued group (1.6 ± 1.5; P < 0.001); serum albumin and creatinine levels were significantly lower. Twenty-six patients (26%) had no symptoms of depression (BDI score <10), and 74 patients (74%) had symptoms of depression (BDI score >9). Patients with a BDI score >9 were older; had a higher CCI; a lower MMSE; a higher TIRD; lower serum albumin, creatinine, and urea levels; and higher serum IL-6 levels. The correlation analyses showed that the score of the SF-36 Vitality subscale was associated with age, dialytic age, TIRD, ADL, IADL, CCI, BDI, HARS, MMSE, serum urea, creatinine, albumin, and IL-6 levels. On multivariate general linear model analyses, with fatigue as the dependent variable and gender as a second factor, BDI and serum IL-6 levels were independently associated with the score of the SF-36 Vitality subscale. A canonical correlation analysis was performed including in the model fatigue, BDI, and biomarkers; the correlation was 0.679 (R(2) = 0.462). Fatigue, BDI, and IL-6 among biomarkers showed the strongest association with the underlying construct (standardized canonical coefficients = -0.989, 0.015, and 0.852, respectively), thus explaining a correlation of IL-6 with both depression and fatigue., Conclusion: Fatigue was significantly associated with symptoms of depression and serum IL-6 levels in patients receiving chronic HD., (Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
34. Fatigue Is Associated with Increased Risk of Mortality in Patients on Chronic Hemodialysis.
- Author
-
Bossola M, Di Stasio E, Antocicco M, Panico L, Pepe G, and Tazza L
- Subjects
- Aged, Depression complications, Female, Humans, Kidney Failure, Chronic complications, Kidney Failure, Chronic mortality, Male, Middle Aged, Risk Assessment, Surveys and Questionnaires, Fatigue complications, Kidney Failure, Chronic therapy, Renal Dialysis
- Abstract
Background: Little is known about the correlation between fatigue and survival in patients on chronic hemodialysis and whether fatigue is an independent predictor of outcome above and beyond the effects of depression. The aim of the present study was to determine if fatigue is a predictor of mortality in patients on chronic hemodialysis (CHP) and if this occurs independently of the symptoms of depression., Methods: CHP referring to the Hemodialysis Service of the Università Cattolica of Rome, Italy between November 2007 and January 2015 were studied. Demographic, clinical, and laboratory data were recorded for each patient at the moment of the inclusion in the study. Fatigue levels were assessed in patients using the Vitality Scale of SF-36 (SF-36 VS), functional ability by the activities of daily living (ADL) and instrumental activities of daily living (IADL), depressive symptoms through the Geriatric Depression Scale (GDS), cognitive function using the Mini Mental State Examination (MMSE), and comorbidity through the Charlson Comorbidity Index (CCI). Patients were grouped into four groups (quartiles): Quartile 1 (Q1), >65; Q2, ≥50 to <65; Q3, ≥35 to <50; Q4, <35., Results: We studied 126 patients: 11 were transplanted and 53 died. Patients who later died were older and had a worse cognitive performance, higher CCI and GDS scores, lower ADL, IADL and SF-36 VS scores, lower serum creatinine and albumin levels. Kaplan-Meier survival was significantly lower in Q4 than in Q1 (p = 0.0001). According to Cox regression analysis, higher fatigue (Q4) was associated with a higher risk of mortality (HR, 95% CI: 5.29, 2.2-12.73)., Conclusion: Fatigue is associated with an increased risk of mortality in CHP, with the relationship independent of symptoms of depression. Fatigue should be assessed routinely and may be a potential target of interventions that aim to reduce mortality in CHP., (© 2015 S. Karger AG, Basel.)
- Published
- 2015
- Full Text
- View/download PDF
35. Cognitive performance is associated with left ventricular function in older chronic hemodialysis patients: result of a pilot study.
- Author
-
Bossola M, Laudisio A, Antocicco M, Tazza L, Colloca G, Tosato M, and Zuccalà G
- Subjects
- Aged, Echocardiography methods, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Pilot Projects, Cognition physiology, Cognition Disorders physiopathology, Renal Dialysis psychology, Renal Insufficiency, Chronic physiopathology, Renal Insufficiency, Chronic psychology, Ventricular Function, Left physiology
- Abstract
Background: Cognitive impairment is a common finding in end-stage renal disease patients on chronic hemodialysis, but data on the associated factors are still scanty., Aims: The present study evaluated the association between cognitive function and left ventricular systolic function in hemodialysis patients., Methods: We enrolled 72 patients admitted to the Hemodialysis Unit of the Catholic University, Rome. Cognitive performance was evaluated using the Mini Mental State Examination (MMSE); a cutoff of 24 was used to diagnose cognitive impairment. Left ventricular ejection fraction (LVEF) was assessed by echocardiography. Multivariable linear and logistic regressions were adopted to assess the adjusted association between cognitive performance and LVEF. Also, linear discriminant analysis was performed to ascertain the cutoff level of LVEF which best predicted cognitive impairment., Results: Cognitive impairment was found in 37 (51 %) patients. According to linear regression, MMSE was independently associated with LVEF (B = 0.06; 95 % CI = 0.01-0.12; P = 0.040). Logistic regression confirmed the inverse association between LVEF and cognitive impairment (OR = 0.87; 95 % CI = 0.78-0.98; P = 0.022). In linear discriminant analysis, the LVEF cutoff level that best predicted cognitive impairment was ≤51 %., Conclusion: Cognitive impairment is a common finding in hemodialysis patients. Even mildly depressed LVEF is independently associated with cognitive impairment. This association and its potential therapeutic implications should be assessed in dedicated studies.
- Published
- 2014
- Full Text
- View/download PDF
36. Nutritional supplement use in hemodialysis patients.
- Author
-
Bossola M and Tazza L
- Subjects
- Female, Humans, Male, Dietary Proteins administration & dosage, Dietary Supplements, Renal Dialysis mortality
- Published
- 2014
- Full Text
- View/download PDF
37. Dietary intake of trace elements, minerals, and vitamins of patients on chronic hemodialysis.
- Author
-
Bossola M, Di Stasio E, Viola A, Leo A, Carlomagno G, Monteburini T, Cenerelli S, Santarelli S, Boggi R, Miggiano G, Vulpio C, Mele C, and Tazza L
- Subjects
- Aged, Aged, 80 and over, Ascorbic Acid, Calcium, Copper, Female, Food, Humans, Iron, Magnesium, Male, Middle Aged, Phosphorus, Potassium, Sodium, Vitamin A, Vitamin B Complex, Vitamin E, Zinc, Diet Records, Kidney Failure, Chronic therapy, Minerals administration & dosage, Renal Dialysis, Trace Elements administration & dosage, Vitamins administration & dosage
- Abstract
Purpose: We aimed to estimate dietary intakes of trace elements, minerals, and vitamins in hemodialysis patients (HDP) of three centers in one metropolitan and two urban areas of Italy., Methods: Daily dietary intake was assessed using a 3-day diet diary in 128 HDP., Results: Mean daily intakes of trace elements were as follows: zinc, 7.6 ± 5.4 mg; copper, 14.3 ± 11.8 mg; selenium, 28.3 ± 18.1 μg; and iron, 7.2 ± 4.1 mg (7.8 ± 2.6 mg in women, 6.9 ± 2.4 mg in men). The distribution of patients by daily intakes of trace elements showed most were under the recommended values, with the exception of copper intake, which was much higher. Mean daily intakes of minerals were as follows: magnesium, 174.4 ± 94.3 mg; phosphorus, 842.6 ± 576.8 mg; calcium, 371.8 ± 363.7 mg; potassium, 1,616.2 ± 897.3 mg; and sodium, 1,350 ± 1,281 mg. Mean daily intakes of vitamins were as follows: vitamin A, 486.1 ± 544.6 μg; vitamin B1, 0.86 ± 0.7 mg; vitamin B2, 1.1 ± 0.7 mg; vitamin B3, 13.3 ± 8.1 mg; vitamin C, 47.8 ± 50.3 mg; and vitamin E, 9.5 ± 3.6 mg. The distribution of patients by daily intakes of vitamins showed most were under the recommended values. Daily intakes of trace elements and vitamins were similar among the three centers and did not differ between dialysis and non-dialysis days., Conclusions: Many HDP have daily dietary intakes of trace elements and vitamins below the recommended values, whereas the intake of copper is much higher.
- Published
- 2014
- Full Text
- View/download PDF
38. Self-reported physical activity in patients on chronic hemodialysis: correlates and barriers.
- Author
-
Bossola M, Pellu V, Di Stasio E, Tazza L, Giungi S, and Nebiolo PE
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Kidney Failure, Chronic physiopathology, Kidney Failure, Chronic therapy, Leisure Activities psychology, Logistic Models, Male, Middle Aged, Motivation, Self Report, Surveys and Questionnaires, Dyspnea physiopathology, Fatigue physiopathology, Kidney Failure, Chronic psychology, Motor Activity, Renal Dialysis
- Abstract
Background and Aims: The knowledge of the barriers that are associated with decreased physical activity (PA) in patients on chronic hemodialysis (PCH) may be of primary importance for the nephrologists. Thus, we aimed to assess the barriers associated with the absent or reduced PA in PCH of a Mediterranean country., Methods: Patients were invited to answer the question 'How often do you exercise during your leisure time?'. Also, patients included in the study were asked to answer questions regarding barriers to physical activity lower than desired., Results: We studied 105 patients. Forty (38.1%) patients reported to never exercise, 6 (5.7%) reported to exercise less than once/week, 4 (3.8%) once/week, 23 (21.9%) two to three times/week, 12 (11.4%) four to five times/week and 20 (19%) daily. Overall, 46 (43.8%) patients never exercised or exercised less than once/week ('inactive') and 59 (56.2%) did exercise more often ('active'). At the multivariate analysis, reduced walking ability, fatigue on the non-dialysis days, and shortness of breath were independently and negatively associated with PA. The same results were found when the reduced model of the multivariate logistic backward regression was built introducing in the model also clinical and laboratory variables., Conclusion: In PCH, fatigue on the non-dialysis days, reduced walking ability, and shortness of breath are barriers independently associated to decreased PA. Knowledge about the causes and mechanisms that generate these barriers has to be acquired., (© 2014 S. Karger AG, Basel.)
- Published
- 2014
- Full Text
- View/download PDF
39. Xerostomia is associated with old age and poor appetite in patients on chronic hemodialysis.
- Author
-
Bossola M, Di Stasio E, Giungi S, Vulpio C, Papa V, Rosa F, Tortorelli A, and Tazza L
- Subjects
- Aged, Cross-Sectional Studies, Feeding and Eating Disorders complications, Female, Humans, Interleukin-6 blood, Kidney Failure, Chronic therapy, Male, Middle Aged, Xerostomia blood, Xerostomia complications, Aging, Appetite, Kidney Failure, Chronic complications, Renal Dialysis, Xerostomia epidemiology
- Abstract
Objective: The objective of this study was to assess variables associated with xerostomia in patients on chronic hemodialysis (HD)., Design and Methods: This was a cross-sectional study of 75 HD patients at an outpatient HD service. Demographic, clinical (renal disease, HD regimen/duration, Charlson comorbidity index, activities of daily living, instrumental activities of daily living [IADL], body mass index), and laboratory (hemoglobin, albumin, interleukin-6 [IL-6], and parathyroid hormone) parameters were recorded. We assessed the appetite through the Hemodialysis Study Appetite questionnaire and xerostomia through the Xerostomia Inventory (XI). A single question ("How often does your mouth feel dry?"; never = Class 1, almost never = Class 2, occasionally = Class 3, often = Class 4, very often = Class 5) was also included in the study questionnaire., Main Outcome Measure: The main outcome measure was factors correlated with XI., Results: The median XI score was 18 (min-max = 11-33). Forty patients had an XI score of 18 or less (Group 1) and between 18 and 35 (Group 2). In Group 2, age, Charlson comorbidity index score, and number of patients with poor/very poor appetite were significantly higher. At the univariate analysis, the score of the XI was significantly associated with age, appetite, IADL, Charlson comorbidity index, and serum IL-6 levels. Multiple linear regression analysis showed that the XI was independently associated with age and appetite. Thirty-one patients were in Class 1 to 2, 23 were in Class 3, and 21 were in Class 4 to 5. In Classes 4 to 5, age and the number of patients with poor/very poor appetite were higher (P = .012 and .09, respectively)., Conclusion: Xerostomia is associated with old age and poor appetite in patients on chronic HD., (Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
40. [The Italian Registry of Vascular Access].
- Author
-
Napoli M, Tazza L, Postorino M, Bonucchi D, Lodi M, Granata A, Lomonte C, Meola M, and Spina M
- Subjects
- Humans, Italy, Registries, Renal Dialysis, Vascular Access Devices
- Abstract
The Vascular Access Study Group of Italian Society of Nephrology has designed a National Register in order to create an archive that collects the data on vascular accesses more detailed than the mere indication of arteriovenous fistula with native vessels, prosthetic fistula and central venous catheter. The obstacles to such a project are represented by the absence of "uniformity" in the name of the arterovenous fistula, the difficulty in increasing the daily work of dialysis centers with another registry and finally by privacy concerns. In order to standardize the vascular accesses name the Study Group proposal is to eliminate any denomination and adopt a code-descriptive system, indicating the seat of the anastomosis (1/3 distal, middle and proximal forearm, arm or lower limb), the limb (if dominant or non-dominant), the vessels involved, the type of anastomosis and the number of interventions that the pt has undergone including the last one. In this way, uniformity and universality are guaranteed. Every aspect scribed will be a cell of a data base and can used to statistical analysis. The study group has set up a software (Gev@) in order to facilitate data storage. The software is based on a form compiled at the end of each surgical procedure. The form will then be archived in digital format thereby generating automatically the data base. The advantage of this system, is represented by the possibility of turning a routine medical procedure, namely the recording of a surgical procedure, in a data base exportable for the creation of the register. As regards the issue of privacy will be obtained the patient's consent to the processing of data and the register will be stored and managed according to the regulations in terms of privacy. In the coming months, after a time of testing, the software will be available to each italian dialisys center.
- Published
- 2013
41. Intradialytic hypotension is associated with dialytic age in patients on chronic hemodialysis.
- Author
-
Bossola M, Laudisio A, Antocicco M, Panocchia N, Tazza L, Colloca G, Tosato M, and Zuccalà G
- Subjects
- Adult, Aged, Female, Humans, Kidney Failure, Chronic therapy, Male, Middle Aged, Regression Analysis, Time Factors, Hypotension etiology, Renal Dialysis adverse effects
- Abstract
Objective: Intradialytic hypotension (IDH) is common in patients on chronic hemodialysis, but knowledge on determinants is still unclear. The present study aims at evaluating the association between IDH and dialytic age (DA) in patients on chronic hemodialysis., Methods: Between January 2012 and January 2013, 82 patients on chronic hemodialysis for at least 1 year were screened for inclusion in the present study. Of these, 14 were excluded because of advanced heart failure (n.9), history of alcohol/substance abuse (n.1), diagnosis of dementia (n.2), actual instability of clinical conditions requiring hospitalization (n.2). IDH was defined as a decrease in systolic blood pressure ≥20 mmHg or a decrease in mean arterial pressure (MAP) by 10 mmHg associated with clinical events and need for nursing interventions. The number of IDH episodes in 10 consecutive hemodialysis sessions was recorded for each patient. Linear and logistic regressions were adopted to assess the adjusted association between IDH and DA., Results: The mean DA was 92 ± 81. Eleven patients (16%) experienced IDH. DA was associated with IDH (OR = 1.01; 95% CI = 1.01-1.02; p = 0.048), after adjusting for potential confounders. DA was associated with the numbers of IDH events in the unadjusted model (B = 0.02; 95% CI = 0.01-0.03; p = 0.042), after adjusting for age and sex (B = 0.01; 95% CI = 0.01-0.03; p = 0.042) as well as in the multivariable model (B = 0.02; 95% CI = 0.01-0.05; p = 0.045)., Conclusion: DA is associated with an increased probability of IDH and with increased number of IHD events. Studies are needed to understand the underlying factors of such an association.
- Published
- 2013
- Full Text
- View/download PDF
42. Ethical evaluation of risks related to living donor transplantation programs.
- Author
-
Panocchia N, Bossola M, Silvestri P, Midolo E, Teleman AA, Tazza L, Sacchini D, Minacori R, Di Pietro ML, and Spagnolo AG
- Subjects
- Humans, Ethics, Living Donors, Risk Assessment
- Abstract
The shortage of available cadaveric organs for transplantation and the growing demand has incresed live donation. To increase the number of transplantations from living donors, programs have been implemented to coordinate donations in direct or indirect form (cross-over, paired, and domino chain). Living donors with complex medical conditions are accepted by several transplantation programs. In this way, the number of transplants from living has exceeded that from cadaver donors in several European countries. No mortality has been reported in the case of lung, pancreas, or intestinal Living donations, but the perioperative complications range from 15% to 30% for pancreas and lung donors. In living kidney donors, the perioperative mortality is 3 per 10,000. Their frequency of end-stage renal disease does not exceed the United States rate for the general population. However, long-term follow-up studies of living donors for kidney transplantations have several limitations. The frequency of complications in live donor liver transplantation is 40%, of these, 48% are possibly life-threatening according to the Clavien classification. Residual disability, liver failure, or death has occurred in 1% of cases. The changes in live donor acceptance criteria raise ethical issues, in particular, the physician's role in evaluating and accepting the risks taken by the living donor. Some workers argue to set aside medical paternalism on behalf of the principle of donor autonomy. In this way the medical rule "primum non nocere" is overcome. Transplantation centers should reason beyond the shortage of organs and think in terms of the care for both donor and recipient., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
43. Dietary intake of macronutrients and fiber in Mediterranean patients on chronic hemodialysis.
- Author
-
Bossola M, Leo A, Viola A, Carlomagno G, Monteburini T, Cenerelli S, Santarelli S, Boggi R, Miggiano G, Vulpio C, Mele C, and Tazza L
- Subjects
- Aged, Calcium, Dietary administration & dosage, Diet Records, Energy Intake, Fatty Acids, Omega-3 administration & dosage, Fatty Acids, Omega-6 administration & dosage, Feeding Behavior, Female, Humans, Italy, Magnesium administration & dosage, Male, Middle Aged, Phosphorus administration & dosage, Cardiovascular Diseases prevention & control, Dietary Carbohydrates administration & dosage, Dietary Fats administration & dosage, Dietary Fiber administration & dosage, Dietary Proteins administration & dosage, Nutrition Policy, Renal Dialysis
- Abstract
Background: We aimed to measure the dietary intake of calories, proteins, carbohydrates, lipids and fiber in patients on chronic hemodialysis (HD) at 3 centers in 1 metropolitan and 2 urban areas of Italy, and to evaluate whether it met the dietary guidelines for cardiovascular risk reduction., Methods: Daily dietary intake was assessed through a 3-day diet diary in 128 HD patients at the hemodialysis units of the Catholic University of Rome, Hospital A. Murri of Jesi and Hospital Principe di Piemonte of Senigallia, Italy., Results: Mean dietary calorie and protein intakes were 22.9 ± 9.1 kcal/kg per day and 0.95 ± 0.76 g protein/kg per day, respectively. Daily carbohydrate and lipid intakes as a percentage of total calorie intake were 51.8% ± 8.9% and 32.1% ± 7.1%. Mean daily dietary cholesterol intake was 206.6 ± 173.6 mg. Mean daily dietary intakes of omega-3 and omega-6 fatty acids were 0.49 ± 0.28 g and 5.1 ± 2.5 g, respectively, while the mean ratio of omega-6 to omega-3 intake was 11.5 ± 4.8. Forty-eighty percent of patients had an omega-6 to omega-3 ratio =10. Mean daily dietary intakes of saturated fatty acids (SFAs), monounsaturated fatty acids and polyunsaturated fatty acids were 5.5 ± 3.3 g, 28.9 ± 9.1 g and 3.1 ± 1.7 g, respectively. Ninety-six percent of HD patients had an SFA intake <10% of total calories. Most unsaturated fatty acids intakes were under the value of =30%. Mean daily dietary fiber intake was 11.8 ± 6.1 g., Conclusion: In HD patients from a Mediterranean country (Italy), daily intakes of calories, proteins and fiber were lower than the recommended values, whereas the intake of lipids was closer to being adequate.
- Published
- 2013
- Full Text
- View/download PDF
44. Appetite and the risk of death in patients on chronic hemodialysis.
- Author
-
Bossola M and Tazza L
- Subjects
- Female, Humans, Male, Anorexia complications, Appetite, Renal Insufficiency, Chronic mortality
- Published
- 2013
- Full Text
- View/download PDF
45. Appetite course over time and the risk of death in patients on chronic hemodialysis.
- Author
-
Bossola M, Di Stasio E, Rosa F, Dominici L, Antocicco M, Pazzaglia C, Aprile I, and Tazza L
- Subjects
- Adult, Age Factors, Aged, Cohort Studies, Confidence Intervals, Female, Humans, Kaplan-Meier Estimate, Kidney Failure, Chronic diagnosis, Logistic Models, Longitudinal Studies, Male, Middle Aged, Monitoring, Physiologic methods, Multivariate Analysis, Nutritional Status, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Renal Dialysis methods, Risk Assessment, Sex Factors, Survival Analysis, Time Factors, Appetite, Cause of Death, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Renal Dialysis mortality
- Abstract
Purpose: Appetite in patients on chronic hemodialysis (HD) may be constantly very good/good or fair/poor or may fluctuate up and down over time. When constantly fair/poor, appetite has been shown to be associated with older age, more comorbidities, and more hospitalizations; however, it is unknown if it predicts survival. The aim of the present study was to assess appetite monthly for 6 months in patients on chronic HD and to determine if the course of appetite over time predicts mortality., Methods: Ninety-two HD patients were evaluated at baseline for appetite, nutritional and inflammatory markers, comorbid conditions, and Charlson's comorbidity index. Appetite assessment was repeated monthly for 6 consecutive months. Survival in relation with the course of appetite over time was determined., Results: Appetite was constantly very good/good in 45 patients (Group 1), fair/poor/very poor in 30 (Group 2), and fluctuated in 17 (Group 3). Twenty-seven (29.3 %) patients died after a mean period of 28 ± 13 months. Overall, the mean survival time was 42.1 ± 1.2 months. For Groups 1, 2, and 3, the mean survival time was 46.1 ± 0.92, 37.9 ± 2.5, and 39.1 ± 3.7 months, respectively (p < 0.0001). After multivariate logistic regression analysis, the course of appetite over time was not found to be an independent risk factor for mortality., Conclusions: The course of appetite over time does not seem to predict mortality in patients on chronic hemodialysis. Considering that the study included a relatively small number of patients, larger similar studies are desirable.
- Published
- 2013
- Full Text
- View/download PDF
46. Variables associated with time of recovery after hemodialysis.
- Author
-
Bossola M, Di Stasio E, Antocicco M, Silvestri P, and Tazza L
- Subjects
- Fatigue etiology, Female, Humans, Kidney Failure, Chronic complications, Male, Middle Aged, Recovery of Function, Time Factors, Kidney Failure, Chronic therapy, Renal Dialysis adverse effects
- Abstract
Background: The aim of this study was to evaluate the relationship among time of recovery after hemodialysis (TIRD) and the demographic, social, clinical and laboratory characteristics of hemodialysis patients of a Mediterranean country., Methods: One hundred hemodialysis patients were invited to answer the following question: "How long does it take you to recover from a dialysis session?" Demographic, clinical (Charlson Comorbidity Index [CCI], Mini-Mental State Examination [MMSE] and Geriatric Depression Scale [GDS]) and laboratory variables were recorded, and fatigue qualities (FQs) were assessed through 5 questions: Do you feel tired much of the time? (general); Do you feel that life is empty? (emotional); Do you have trouble concentrating? (cognitive); Do you have difficulty sleeping? (sleepiness); Do you have muscle weakness? (weakness); and Do you feel full of energy? (lack of energy)., Results: The means ± SD of TIRD was 205.5 ± 198.6 minutes: 79 patients reported a TIRD =4 hours, and 21 =2 hours. TIRD did not differ between males and females (p = 0.382), patients with and without diabetes (p = 0.581), patients with and without coronary disease (p = 0.095), and patients with and without cerebrovascular disease (p = 0.941). CCI, the number of FQs, and GDS and MMSE scores were significantly correlated with the TIRD at univariate analysis. At multiple regression analysis, the number of FQs was related to the TIRD (coefficient 46.99; SE = 17.04; p = 0.008). Excluding the variable FQ, the GDS was independently associated with TIRD (coefficient 3.21; SE = 9.26; p = 0.729)., Conclusion: TIRD was independently associated with the number of FQs. When that variable was excluded from the analysis, TIRD was independently associated with the GDS.
- Published
- 2013
- Full Text
- View/download PDF
47. Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.
- Author
-
Vulpio C, Bossola M, Di Stasio E, Tazza L, Silvestri P, and Fadda G
- Subjects
- Adult, Aged, Cinacalcet, Female, Humans, Hyperparathyroidism, Secondary drug therapy, In Vitro Techniques, Male, Middle Aged, Renal Dialysis, Retrospective Studies, Hyperparathyroidism, Secondary metabolism, Hyperparathyroidism, Secondary pathology, Immunohistochemistry, Naphthalenes therapeutic use, Parathyroid Glands metabolism, Vitamin D therapeutic use
- Abstract
Background: Cinacalcet is a new effective treatment of secondary hyperparathyroidism (SHPT) in hemodialysis patients (HP), but the alterations of parathyroid gland (PTG) hyperplasia determined by cinacalcet and vitamin D have not been extensively investigated in humans., Methods: We performed histological analyses of 94 PTGs removed from 25 HP who underwent parathyroidectomy (PTx) because of SHPT refractory to therapy with vitamin D alone (group A=13 HP and 46 PTGs) or associated with cinacalcet (group B=12 HP and 48 PTGs). The number, weight, the macroscopic cystic/hemorrhagic changes, and type of hyperplasia of PTG (nodular=NH, diffuse=DH) were assessed. In randomly selected HP of group A (4 HP and 14 PTGs) and group B (4 HP and 15 PTGs), the labeling index of cells positive to Ki-67 and TUNEL and the semiquantitative score of immunohistochemistry staining of vitamin D receptor, calcium-sensing receptor, and vascular endothelial growth factor-α (VEGF-α) were measured in the entire PTGs and in the areas with DH or NH., Results: The number and weight of single and total PTG of each HP were similar in the two groups as well as the number of PTG with macroscopic cystic/hemorrhagic areas. TUNEL, Ki-67, and VEGF-α scores were higher in NH than in DH areas., Conclusion: This observational study of a highly selected population of HP, submitted to PTx because SHPT refractory to therapy, shows that the macroscopic, microscopic, and immunochemistry characteristics of PTG in HP who received or did not receive cinacalcet before PTx did not differ significantly.
- Published
- 2013
- Full Text
- View/download PDF
48. Appetite is associated with the time of recovery after the dialytic session in patients on chronic hemodialysis.
- Author
-
Bossola M and Tazza L
- Subjects
- Cross-Sectional Studies, Female, Humans, Italy epidemiology, Male, Middle Aged, Prevalence, Renal Insufficiency, Chronic diagnosis, Treatment Outcome, Activities of Daily Living, Appetite, Recovery of Function, Renal Dialysis methods, Renal Insufficiency, Chronic physiopathology, Renal Insufficiency, Chronic rehabilitation
- Abstract
Aim: The aim of this cross-sectional study was to assess the correlation between self-reported appetite and the time of recovery after the hemodialysis session (TIRD)., Methods: All patients on chronic hemodialysis at the Hemodialysis Service of the Catholic University of Rome underwent assessment of appetite through the first three questions of the Hemodialysis Study Appetite questionnaire, TIRD (through the question 'How long does it take you to recover from a dialysis session?'), number and severity of comorbidities according to the Charlson Comorbidity Index (CCI), and daily activities through the ADL (activities of daily living) and the IADL (instrumental activities of daily living)., Results: We studied 106 patients. According to the appetite questionnaire, in 45 patients appetite was very good or good (group 1), in 33 fair (group 2) and in 28 poor or very poor (group 3). Age, CCI, TIRD and serum parathyroid hormone levels were significantly higher in group 3 than in groups 1 and 2, while the IADL was significantly lower. Age, CCI, TIRD, IADL and serum parathyroid hormone were significantly correlated with appetite. At multiple regression analysis, TIRD and CCI only were independently correlated with appetite., Conclusion: Poor appetite is independently associated with the time of recovery after the hemodialysis session., (Copyright © 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
49. Qualities of fatigue in patients on chronic hemodialysis.
- Author
-
Bossola M, Di Stasio E, Antocicco M, and Tazza L
- Subjects
- Activities of Daily Living, Comorbidity, Depression etiology, Depression psychology, Fatigue psychology, Female, Humans, Male, Middle Aged, Fatigue etiology, Kidney Failure, Chronic complications, Kidney Failure, Chronic therapy, Renal Dialysis adverse effects, Renal Dialysis psychology
- Abstract
We aimed to assess the relationship among fatigue qualities (FQ) and the association of FQ with various characteristics of chronic hemodialysis (HD) patients. In 68 HD patients, we assessed the Charlson Comorbidity Index (CCI), the Geriatric Depression Scale score (GDS), the Mini Mental Status Examination (MMSE), and measured the laboratory parameters. In addition, patients answered to six questions about FQ (Tiredness: Do you feel tired much of the time? Emotional: Do you feel that life is empty? Cognitive: Do you have trouble concentrating? Sleepiness: Have you had difficulty sleeping in the past month? Weakness: Have you had muscle weakness in the past month? Lack of energy: Do you feel full of energy?). At least one FQ was reported by 62 patients. Muscle weakness (61.7%) was the most frequent and cognitive fatigue (22%) the least. Physical FQ were all more common than the mental ones. Correlation between the two mental FQ (emotional and cognitive) was 0.381 (p = 0.002). Six patients reported none of the FQ, 20 one FQ, 13 two FQ, and 29 three or more FQ. CCI and GDS were associated with all FQ and MMSE with all FQ but sleepiness. Patients reporting ≥3 FQ were older, had more comorbidities, more symptoms of depression, and a lower MMSE score. At multivariate linear regression analysis, the GDS was the only significant predictor of the number of FQ. HD patients report a variety of qualities of fatigue and the number of FQ is independently associated with symptoms of depression., (© 2012 The Authors. Hemodialysis International © 2012 International Society for Hemodialysis.)
- Published
- 2013
- Full Text
- View/download PDF
50. Measurement of 25-hydroxyvitamin vitamin D by liquid chromatography tandem-mass spectrometry with comparison to automated immunoassays.
- Author
-
Carrozza C, Persichilli S, Canu G, Gervasoni J, Torti E, Tazza L, and Zuppi C
- Subjects
- Automation, Humans, Vitamin D blood, Blood Chemical Analysis methods, Chromatography, Liquid methods, Immunoassay methods, Tandem Mass Spectrometry methods, Vitamin D analogs & derivatives
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.